FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Sauce, B
   Goes, CP
   Forti, I
   do Monte, BGO
   Watanabe, IM
   Cunha, J
   Peripato, AC
AF Sauce, Bruno
   Goes, Carolina P.
   Forti, Isabela
   do Monte, Bruno Gabriel O.
   Watanabe, Isabela M.
   Cunha, Joao
   Peripato, Andrea C.
TI A link between thrifty phenotype and maternal care across two
   generations of intercrossed mice
SO PLOS ONE
LA English
DT Article
ID ELEVATED PLUS-MAZE; LG/J X SM/J; FORCED SWIMMING TEST;
   INDIVIDUAL-DIFFERENCES; EPIGENETIC MECHANISMS; GENETIC ARCHITECTURE;
   GESTATIONAL-AGE; MILK EJECTION; MOUSE STRAINS; ANIMAL-MODEL
AB Maternal effects are causal influences from mother to offspring beyond genetic information, and have lifelong consequences for multiple traits. Previously, we reported that mice whose mothers did not nurse properly had low birth weight followed by rapid fat accumulation and disturbed development of some organs. That pattern resembles metabolic syndromes known collectively as the thrifty phenotype, which is believed to be an adaptation to a stressful environment which prepares offspring for reduced nutrient supply. The potential link between maternal care, stress reactivity, and the thrifty phenotype, however, has been poorly explored in the human and animal literature: only a couple of studies even mention (much less, test) these concepts under a cohesive framework. Here, we explored this link using mice of the parental inbred strains SM/J and LG/J-who differ dramatically in their maternal care-and the intercrossed generations F1 and F2. We measured individual differences in 15 phenotypes and used structural equation modeling to test our hypotheses. We found a remarkable relationship between thrifty phenotype and lower quality of maternal behaviors, including nest building, pup retrieval, grooming/licking, and nursing. To our knowledge, this is the first study to show, in any mammal, a clear connection between the natural variation in thrifty phenotype and maternal care. Both traits in the mother also had a substantial effect on survival rate in the F3 offspring. To our surprise, however, stress reactivity seemed to play no role in our models. Furthermore, the strain of maternal grandmother, but not of paternal grandmother, affected the variation of maternal care in F2 mice, and this effect was mediated by thrifty phenotype in F2. Since F1 animals were all genetically identical, this finding suggests that maternal effects pass down both maternal care and thrifty phenotype in these mice across generations via epigenetic transmission.
C1 [Sauce, Bruno] Rutgers State Univ, Dept Psychol, Program Behav & Syst Neurosci, Piscataway, NJ USA.
   [Goes, Carolina P.] Univ Sao Paulo, Inst Biomed Sci, Program Cellular Biol & Histol, Sao Paulo, Brazil.
   [Forti, Isabela; do Monte, Bruno Gabriel O.; Watanabe, Isabela M.; Cunha, Joao; Peripato, Andrea C.] Univ Fed Sao Carlos, Ctr Hlth & Biol Sci, Dept Genet & Evolut, Sao Carlos, SP, Brazil.
RP Peripato, AC (reprint author), Univ Fed Sao Carlos, Ctr Hlth & Biol Sci, Dept Genet & Evolut, Sao Carlos, SP, Brazil.
EM peripato@ufscar.br
RI Sauce, Bruno/X-4365-2018
OI Sauce, Bruno/0000-0002-9544-0150; Purcell Goes,
   Carolina/0000-0002-4086-3519
FU Fundacao de Amparo a pesquisa do Estado de Sao Paulo [2004/14583-9,
   2013/22339-0, 2007/06254-3]
FX This study was funded by grants 2004/14583-9 and 2013/22339-0 from
   Fundacao de Amparo a pesquisa do Estado de Sao Paulo
   (http://www.fapesp.br/en/) to AP, and grant 2007/06254-3 from from
   Fundacao de Amparo a pesquisa do Estado de Sao Paulo
   (http://www.fapesp.br/en/) to BS. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ANDERSON TW, 1957, J AM STAT ASSOC, V52, P200, DOI 10.2307/2280845
   Andreatini R, 1999, BRAZ J MED BIOL RES, V32, P1121, DOI 10.1590/S0100-879X1999000900011
   Barnes SK, 2011, PROG BIOPHYS MOL BIO, V106, P323, DOI 10.1016/j.pbiomolbio.2010.12.005
   Bekku N, 2005, PSYCHOPHARMACOLOGY, V183, P300, DOI 10.1007/s00213-005-0179-0
   Berghanel A, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1304
   BRINDLEY DN, 1989, CLIN SCI, V77, P453, DOI 10.1042/cs0770453
   Bult A, 1997, BEHAV GENET, V27, P231, DOI 10.1023/A:1025610130282
   Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335
   Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925
   Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5
   Champagne FA, 2007, PHYSIOL BEHAV, V91, P325, DOI 10.1016/j.physbeh.2007.03.014
   Champagne FA, 2009, NEUROSCI BIOBEHAV R, V33, P593, DOI 10.1016/j.neubiorev.2007.10.009
   Cheverud JM, 2001, MAMM GENOME, V12, P3, DOI 10.1007/s003350010218
   Chiavegatto S, 2012, BRAIN BEHAV, V2, P365, DOI 10.1002/brb3.58
   Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2
   Chou C-P, 1995, STRUCTURAL EQUATION
   DiLalla David L., 2006, PSYCHOL RES HDB GUID, P241, DOI DOI 10.4135/9781412976626.N16
   Ducottet C, 2005, BEHAV BRAIN RES, V156, P153, DOI 10.1016/j.bbr.2004.05.018
   Ehrich TH, 2005, DIABETES, V54, P1863, DOI 10.2337/diabetes.54.6.1863
   Goes CP, 2012, MAMM GENOME, V23, P770, DOI 10.1007/s00335-012-9431-1
   Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5
   HART BL, 1990, PHYSIOL BEHAV, V48, P383, DOI 10.1016/0031-9384(90)90332-X
   Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4
   Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.1037/1082-989X.12.1.58
   Hrbek T, 2006, MAMM GENOME, V17, P417, DOI 10.1007/s00335-005-0038-7
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   HUIZINGA HA, 1986, LIVEST PROD SCI, V15, P11, DOI 10.1016/0301-6226(86)90051-5
   Ibanez L, 2008, J CLIN ENDOCR METAB, V93, P2079, DOI 10.1210/jc.2007-2850
   Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778
   Kline R. B., 2011, PRINCIPLES PRACTICE
   Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3
   Lee HK, 1999, DIABETES RES CLIN PR, V45, P127, DOI 10.1016/S0168-8227(99)00042-X
   Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0
   MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037//1082-989X.1.2.130
   MacKinnon DP, 2007, BEHAV RES METHODS, V39, P384, DOI 10.3758/BF03193007
   MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037//1082-989X.7.1.83
   Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003
   Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161
   MOODY TW, 1988, ANN NY ACAD SCI, V525, P281, DOI 10.1111/j.1749-6632.1988.tb38613.x
   Mousseau T.A., 1998, MATERNAL EFFECTS ADA
   Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4
   Noguera JC, 2011, FUNCT ECOL, V25, P1144, DOI 10.1111/j.1365-2435.2011.01856.x
   Numan M., 2003, NEUROBIOLOGY PARENTA
   Peripato AC, 2004, J EVOLUTION BIOL, V17, P593, DOI 10.1111/j.1420-9101.2004.00702.x
   Peripato AC, 2002, AM NAT, V160, pS173, DOI 10.1086/342900
   Peripato AC, 2002, GENETICS, V162, P1341
   Petry CJ, 1997, P NUTR SOC, V56, P233, DOI 10.1079/PNS19970028
   Plotsky PM, 2005, NEUROPSYCHOPHARMACOL, V30, P2192, DOI 10.1038/sj.npp.1300769
   Porsolt R D, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as14
   Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X
   Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x
   Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017
   Rosmond R, 1998, J CLIN ENDOCR METAB, V83, P1853, DOI 10.1210/jc.83.6.1853
   RUSSELL JA, 1980, J PHYSIOL-LONDON, V303, P403, DOI 10.1113/jphysiol.1980.sp013295
   Sauce B, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00395
   Sauce Bruno, 2012, Frontiers in Genetics, V3, DOI 10.3389/fgene.2012.00090
   Schafer J.L., 2010, ANAL INCOMPLETE MULT
   Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338
   Wells JCK, 2003, J THEOR BIOL, V221, P143, DOI 10.1006/jtbi.2003.3183
   Wells JCK, 2011, AM J HUM BIOL, V23, P65, DOI 10.1002/ajhb.21100
   Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238
NR 61
TC 3
Z9 3
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 19
PY 2017
VL 12
IS 5
AR e0177954
DI 10.1371/journal.pone.0177954
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV3PW
UT WOS:000401672600033
PM 28542485
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Szentagotai-Tatar, A
   Chis, A
   Vulturar, R
   Dobrean, A
   Candea, DM
   Miu, AC
AF Szentagotai-Tatar, Aurora
   Chis, Adina
   Vulturar, Romana
   Dobrean, Anca
   Candea, Diana Mirela
   Miu, Andrei C.
TI Shame and Guilt-Proneness in Adolescents: Gene-Environment Interactions
SO PLOS ONE
LA English
DT Article
ID BDNF VAL66MET POLYMORPHISM; SELF-CONSCIOUS EMOTIONS; EARLY-LIFE STRESS;
   COGNITIVE VULNERABILITY; NEUROTROPHIC FACTOR; DEPRESSION; SEROTONIN;
   CHILDHOOD; 5-HTTLPR; EVENTS
AB Rooted in people's preoccupation with how they are perceived and evaluated, shame and guilt are self-conscious emotions that play adaptive roles in social behavior, but can also contribute to psychopathology when dysregulated. Shame and guilt-proneness develop during childhood and adolescence, and are influenced by genetic and environmental factors that are little known to date. This study investigated the effects of early traumatic events and functional polymorphisms in the brain-derived neurotrophic factor (BDNF) gene and the serotonin transporter gene promoter (5-HTTLPR) on shame and guilt in adolescents. A sample of N = 271 healthy adolescents between 14 and 17 years of age filled in measures of early traumatic events and proneness to shame and guilt, and were genotyped for the BDNF Val66Met and 5-HTTLPR polymorphisms. Results of moderator analyses indicated that trauma intensity was positively associated with guilt-proneness only in carriers of the low-expressing Met allele of BDNF Val66Met. This is the first study that identifies a gene-environment interaction that significantly contributes to guilt proneness in adolescents, with potential implications for developmental psychopathology.
C1 [Szentagotai-Tatar, Aurora; Dobrean, Anca; Candea, Diana Mirela] Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, R-3400 Cluj Napoca, Cluj, Romania.
   [Chis, Adina; Vulturar, Romana] Iuliu Haieganu Univ Med & Pharm, Dept Cell & Mol Biol, Cluj Napoca, Romania.
   [Miu, Andrei C.] Univ Babes Bolyai, Dept Psychol, Cognit Neurosci Lab, R-3400 Cluj Napoca, Cluj, Romania.
RP Szentagotai-Tatar, A (reprint author), Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, R-3400 Cluj Napoca, Cluj, Romania.
EM auraszentagotai@psychology.ro
RI Szentagotai Tatar, Aurora/C-4045-2012; Miu, Andrei C./C-5184-2011
OI Miu, Andrei C./0000-0002-6459-5010
FU Romanian National Authority for Scientific Research, CNCS - UEFISCDI
   [PNII-ID-PCCE-2011-2-0045, PN-II-RU-PD-2012-3-0501]
FX This work was supported by grants from the Romanian National Authority
   for Scientific Research, CNCS - UEFISCDI (http://uefiscdi.gov.ro/),
   grants number PNII-ID-PCCE-2011-2-0045 (ACM) and PN-II-RU-PD-2012-3-0501
   (AC). Although the Romanian National Authority for Scientific Research,
   CNCS - UEFISCDI, provided finding for the collection of data and the
   manuscript preparation, they had no role in the study design, the
   collection, analysis, or interpretation of data, the writing of the
   report, or the decision to submit the manuscript for publication.
CR Aiken L. S., 1991, MULTIPLE REGRESSION
   ANDREWS B, 1995, J ABNORM PSYCHOL, V104, P277, DOI 10.1037/0021-843X.104.2.277
   Andrews B, 2000, J ABNORM PSYCHOL, V109, P69, DOI 10.1037//0021-843X.109.1.69
   Belden AC, 2015, JAMA PSYCHIAT, V72, P40, DOI 10.1001/jamapsychiatry.2014.1604
   Bennett DS, 2010, CHILD MALTREATMENT, V15, P305, DOI 10.1177/1077559510379634
   Blakemore SJ, 2014, ANNU REV PSYCHOL, V65, P187, DOI 10.1146/annurev-psych-010213-115202
   BOX GEP, 1964, J ROY STAT SOC B, V26, P211
   Briggs-Gowan MJ, 2010, J CHILD PSYCHOL PSYC, V51, P1132, DOI 10.1111/j.1469-7610.2010.02256.x
   Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X
   Buka SL., 2007, J CHILD FAM STUD, V16, P859, DOI DOI 10.1007/S10826-006-9130-1
   Burghy CA, 2012, NAT NEUROSCI, V15, P1736, DOI 10.1038/nn.3257
   Carnuta M, 2015, PSYCHONEUROENDOCRINO, V51, P176, DOI 10.1016/j.psyneuen.2014.09.026
   Carver CS, 2011, J AFFECT DISORDERS, V132, P89, DOI 10.1016/j.jad.2011.02.001
   Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925
   Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663
   Claesson K, 2002, CLIN PSYCHOL PSYCHOT, V9, P277, DOI 10.1002/cpp.331
   Cohen J, 1988, STAT POWER ANAL BEHA
   de Hooge IE, 2007, COGNITION EMOTION, V21, P1025, DOI 10.1080/02699930600980874
   de Hooge IE, 2010, COGNITION EMOTION, V24, P111, DOI 10.1080/02699930802584466
   Drabant EM, 2012, AM J PSYCHIAT, V169, P397, DOI 10.1176/appi.ajp.2011.10111699
   Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013
   Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Elzinga BM, 2011, PSYCHOPHARMACOLOGY, V214, P319, DOI 10.1007/s00213-010-1961-1
   Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149
   Feiring C, 2002, DEV PSYCHOL, V38, P79, DOI 10.1037//0012-1649.38.1.79
   Feiring Candice, 2002, Child Maltreat, V7, P26, DOI 10.1177/1077559502007001003
   Ferguson TJ, 2000, GENET SOC GEN PSYCH, V126, P319
   Fletcher KE, 2011, J CHILD ADOLESCENT T, V4, P339
   Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115
   Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143
   Gavazzi IG, 2011, EUR J DEV PSYCHOL, V8, P311, DOI 10.1080/17405629.2010.491303
   Hayden EP, 2008, J AFFECT DISORDERS, V107, P227, DOI 10.1016/j.jad.2007.07.028
   Hayden EP, 2013, DEV PSYCHOPATHOL, V25, P587, DOI 10.1017/S0954579413000035
   Hayes A. F., 2013, INTRO MEDIATION MODE
   HOGLUND CL, 1995, J FAM VIOLENCE, V10, P141, DOI 10.1007/BF02110597
   Holmes A, 2003, NEUROPSYCHOPHARMACOL, V28, P2077, DOI 10.1038/sj.npp.1300266
   Hosang GM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-7
   Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850
   Karabeg MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078238
   Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189
   Lagattuta KH, 2007, SELF CONSCIOUS EMOTI, P91
   Lau JYF, 2010, NEUROIMAGE, V53, P952, DOI 10.1016/j.neuroimage.2009.11.026
   Leary MR, 2004, PSYCHOL INQ, V15, P129
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174
   Lester KJ, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.33
   Lester KJ, 2013, BIOL MOOD ANXIETY DI, V3, DOI 10.1186/2045-5380-3-4
   Lewis H. B., 1971, SHAME GUILT NEUROSIS
   Lewis M., 2007, SELF CONSCIOUS EMOTI, P134
   Lickel B, 2014, EMOTION, V14, P1049, DOI 10.1037/a0038235
   Lovibond SH, 1995, MANUAL DEPRESSION AN
   Luby J, 2009, J CHILD PSYCHOL PSYC, V50, P1156, DOI 10.1111/j.1469-7610.2009.02077.x
   Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571
   Mills RSL, 2015, CHILD PSYCHIAT HUM D, V46, P194, DOI 10.1007/s10578-013-0416-4
   Mills RSL, 2005, DEV REV, V25, P26, DOI 10.1016/j.dr.2004.08.001
   Miu AC, 2013, EMOTION, V13, P1012, DOI 10.1037/a0033383
   Mongillo EA, 2009, J ABNORM CHILD PSYCH, V37, P455, DOI 10.1007/s10802-008-9283-z
   Muris P, 2014, CLIN CHILD FAM PSYCH, V17, P19, DOI 10.1007/s10567-013-0137-z
   Nugent NR, 2011, PSYCHOPHARMACOLOGY, V214, P175, DOI 10.1007/s00213-010-2151-x
   Olthof T, 2004, COGNITION EMOTION, V18, P383, DOI 10.1080/02699930341000077
   Orth U, 2010, J PERS SOC PSYCHOL, V99, P1061, DOI 10.1037/a0021342
   PENNEBAKER JW, 1988, SOC SCI MED, V26, P327, DOI 10.1016/0277-9536(88)90397-8
   Perea CS, 2012, J AFFECT DISORDERS, V136, P767, DOI 10.1016/j.jad.2011.09.043
   Perroud N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.140
   Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24
   Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463
   Plomin R, 2013, PSYCHOL SCI, V24, P562, DOI 10.1177/0956797612457952
   Rakow A, 2011, J FAM PSYCHOL, V25, P147, DOI 10.1037/a0022110
   Rakow A, 2009, J CHILD FAM STUD, V18, P367, DOI 10.1007/s10826-008-9239-5
   Rankin JL, 2004, J RES ADOLESCENCE, V14, P1, DOI 10.1111/j.1532-7795.2004.01401001.x
   Roberts W, 2014, CAN J BEHAV SCI, V46, P465, DOI 10.1037/a0035057
   Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359
   Roos S, 2014, DEV PSYCHOL, V50, P941, DOI 10.1037/a0033904
   Rutter M, 1997, DEV PSYCHOPATHOL, V9, P335, DOI 10.1017/S0954579497002083
   Scherer KR, 2009, EUR J PERSONALITY, V23, P265, DOI 10.1002/per.714
   SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709
   Sharpley CF, 2014, BEHAV BRAIN RES, V273, P89, DOI 10.1016/j.bbr.2014.07.030
   Sheikh HI, 2008, PERS INDIV DIFFER, V45, P425, DOI 10.1016/j.paid.2008.05.020
   Sheikh HI, 2010, PSYCHIAT GENET, V20, P109, DOI 10.1097/YPG.0b013e32833a2038
   Smyth JM, 2008, J AM COLL HEALTH, V57, P69, DOI 10.3200/JACH.57.1.69-76
   Somerville LH, 2013, PSYCHOL SCI, V24, P1554, DOI 10.1177/0956797613475633
   Stuewig J, 2005, CHILD MALTREATMENT, V10, P324, DOI 10.1177/1077559505279308
   Stuewig J, 2015, CHILD PSYCHIAT HUM D, V46, P217, DOI 10.1007/s10578-014-0467-1
   Szabo M, 2010, J ADOLESCENCE, V33, P1, DOI 10.1016/j.adolescence.2009.05.014
   Tangney J. P., 2002, SHAME GUILT
   Tangney JP, 1996, BEHAV RES THER, V34, P741, DOI 10.1016/0005-7967(96)00034-4
   Tangney JP, 1991, TEST SELF CONSCIOUS
   Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145
   Tilghman-Osborne C, 2012, J ABNORM CHILD PSYCH, V40, P607, DOI 10.1007/s10802-011-9591-6
   Tracy JL, 2004, PSYCHOL INQ, V15, P103, DOI 10.1207/s15327965pli1502_01
   van Oostrom I, 2012, BIOL PSYCHOL, V89, P214, DOI 10.1016/j.biopsycho.2011.10.012
   Vinkhuyzen AAE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.27
   Vulturar R, 2012, PSYCHOPHYSIOLOGY, V49, P1412, DOI 10.1111/j.1469-8986.2012.01445.x
   Webb M, 2007, CHILD ABUSE NEGLECT, V31, P1143, DOI 10.1016/j.chiabu.2007.09.003
   Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789
   West SG, 1996, J PERS, V64, P1, DOI 10.1111/j.1467-6494.1996.tb00813.x
   Westenberg PM, 2004, J CHILD PSYCHOL PSYC, V45, P481
   General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14, DOI 10.1001/jama.2013.281053
   Zahn-Waxler Carolyn, 1995, P143
NR 100
TC 6
Z9 6
U1 1
U2 30
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 31
PY 2015
VL 10
IS 7
AR e0134716
DI 10.1371/journal.pone.0134716
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CO0JY
UT WOS:000358838400155
PM 26230319
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Patrono, E
   Di Segni, M
   Patella, L
   Andolina, D
   Valzania, A
   Latagliata, EC
   Felsani, A
   Pompili, A
   Gasbarri, A
   Puglisi-Allegra, S
   Ventura, R
AF Patrono, Enrico
   Di Segni, Matteo
   Patella, Loris
   Andolina, Diego
   Valzania, Alessandro
   Latagliata, Emanuele Claudio
   Felsani, Armando
   Pompili, Assunta
   Gasbarri, Antonella
   Puglisi-Allegra, Stefano
   Ventura, Rossella
TI When Chocolate Seeking Becomes Compulsion: Gene-Environment Interplay
SO PLOS ONE
LA English
DT Article
ID INDUCED CORTICOSTERONE SECRETION; CONDITIONED PLACE PREFERENCE;
   STRESS-INDUCED SENSITIZATION; EXCESSIVE SUGAR INTAKE; DOPAMINE D2
   RECEPTOR; INBRED MOUSE STRAINS; DRUG-ADDICTION; ANIMAL-MODEL;
   EATING-DISORDERS; FOOD ADDICTION
AB Background
   Eating disorders appear to be caused by a complex interaction between environmental and genetic factors, and compulsive eating in response to adverse circumstances characterizes many eating disorders.
   Materials and Methods
   We compared compulsion-like eating in the form of conditioned suppression of palatable food-seeking in adverse situations in stressed C57BL/6J and DBA/2J mice, two well-characterized inbred strains, to determine the influence of gene-environment interplay on this behavioral phenotype. Moreover, we tested the hypothesis that low accumbal D2 receptor (R) availability is a genetic risk factor of food compulsion-like behavior and that environmental conditions that induce compulsive eating alter D2R expression in the striatum. To this end, we measured D1R and D2R expression in the striatum and D1R, D2R and alpha 1R levels in the medial prefrontal cortex, respectively, by western blot.
   Results
   Exposure to environmental conditions induces compulsion-like eating behavior, depending on genetic background. This behavioral pattern is linked to decreased availability of accumbal D2R. Moreover, exposure to certain environmental conditions upregulates D2R and downregulates alpha 1R in the striatum and medial prefrontal cortex, respectively, of compulsive animals. These findings confirm the function of gene-environment interplay in the manifestation of compulsive eating and support the hypothesis that low accumbal D2R availability is a "constitutive" genetic risk factor for compulsion-like eating behavior. Finally, D2R upregulation and alpha 1R downregulation in the striatum and medial prefrontal cortex, respectively, are potential neuroadaptive responses that parallel the shift from motivated to compulsive eating.
C1 [Di Segni, Matteo; Andolina, Diego; Valzania, Alessandro; Latagliata, Emanuele Claudio; Puglisi-Allegra, Stefano; Ventura, Rossella] Santa Lucia Fdn, Rome, Italy.
   [Di Segni, Matteo; Valzania, Alessandro; Latagliata, Emanuele Claudio; Puglisi-Allegra, Stefano; Ventura, Rossella] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy.
   [Di Segni, Matteo; Valzania, Alessandro; Latagliata, Emanuele Claudio; Puglisi-Allegra, Stefano; Ventura, Rossella] Univ Roma La Sapienza, Ctr Daniel Bovet, I-00185 Rome, Italy.
   [Patrono, Enrico; Patella, Loris; Andolina, Diego; Pompili, Assunta; Gasbarri, Antonella] Univ Aquila, Dept Appl Clin Sci & Biotechnol, Coppito, Italy.
   [Felsani, Armando] CNR, Inst Cellular Biol & Neurobiol, Rome, Italy.
RP Ventura, R (reprint author), Santa Lucia Fdn, Rome, Italy.
EM rossella.ventura@uniroma1.it
RI Di Segni, Matteo/K-6000-2016; Felsani, Armando/D-1784-2010
OI Di Segni, Matteo/0000-0002-1453-579X; Felsani,
   Armando/0000-0001-8851-6295; POMPILI, Assunta/0000-0003-2901-5030;
   Gasbarri, Antonella/0000-0003-0708-6524; Emanuele Claudio,
   Latagliata/0000-0001-8402-2757; Patrono, Enrico/0000-0002-9056-9537
FU Ministero dell'Istruzione dell'Universita e della Ricerca: Ateneo
   [C26A13L3PZ]; FIRB, Italy [RBFR10RZ0N_001]
FX The work was supported by Ministero dell'Istruzione dell'Universita e
   della Ricerca: Ateneo 2013 (C26A13L3PZ); FIRB 2010 (RBFR10RZ0N_001),
   Italy.
CR Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011
   Alcaro A, 2007, BRAIN RES REV, V56, P283, DOI 10.1016/j.brainresrev.2007.07.014
   Alsio J, 2012, FRONT NEUROENDOCRIN, V33, P127, DOI 10.1016/j.yfrne.2012.01.002
   Andolina D, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu074
   Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019
   Avena NM, 2012, NEUROPHARMACOLOGY, V63, P87, DOI 10.1016/j.neuropharm.2011.11.010
   Bello NT, 2010, PHARMACOL BIOCHEM BE, V97, P25, DOI 10.1016/j.pbb.2010.04.016
   Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003
   Bertolino A, 2009, BRAIN, V132, P417, DOI 10.1093/brain/awn248
   Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024
   Bray GA, 2004, AM J CLIN NUTR, V79, P537
   Bulik CM, 2005, J PSYCHIATR NEUROSCI, V30, P335
   Cabib S, 1998, NEUROSCIENCE, V84, P193, DOI 10.1016/S0306-4522(97)00468-5
   CABIB S, 1985, BEHAV NEURAL BIOL, V44, P239, DOI 10.1016/S0163-1047(85)90254-7
   Cabib S, 2002, BEHAV BRAIN RES, V130, P103, DOI 10.1016/S0166-4328(01)00422-3
   Cabib S, 2000, SCIENCE, V289, P463, DOI 10.1126/science.289.5478.463
   Cabib S, 2012, NEUROSCI BIOBEHAV R, V36, P79, DOI 10.1016/j.neubiorev.2011.04.012
   Campbell IC, 2011, NEUROSCI BIOBEHAV R, V35, P784, DOI 10.1016/j.neubiorev.2010.09.012
   Carr KD, 2002, PHYSIOL BEHAV, V76, P353, DOI 10.1016/S0031-9384(02)00759-X
   Casper RC, 2008, PSYCHOPHARMACOLOGY, V199, P313, DOI 10.1007/s00213-008-1102-2
   Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925
   Cifani C, 2009, PSYCHOPHARMACOLOGY, V204, P113, DOI 10.1007/s00213-008-1442-y
   Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035
   Colelli V, 2010, GENES BRAIN BEHAV, V9, P703, DOI 10.1111/j.1601-183X.2010.00604.x
   Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001
   Corwin RL, 2011, PHYSIOL BEHAV, V104, P87, DOI 10.1016/j.physbeh.2011.04.041
   Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327
   Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073
   Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100
   DEROCHE V, 1995, J NEUROSCI, V15, P7181
   Dietrich MO, 2009, EUR J NEUROSCI, V30, P1688, DOI 10.1111/j.1460-9568.2009.06963.x
   Drouin C, 2002, J NEUROSCI, V22, P2873, DOI 10.1523/JNEUROSCI.22-07-02873.2002
   Elmer GI, 2010, PSYCHOPHARMACOLOGY, V208, P309, DOI 10.1007/s00213-009-1732-z
   Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089
   Fallon S, 2007, NEUROCHEM RES, V32, P1772, DOI 10.1007/s11064-007-9343-8
   Fetsko LA, 2003, BRAIN RES, V967, P191, DOI 10.1016/S0006-8993(02)04277-4
   Fish E, 2010, TCE-THE CHEM ENG, P2
   Gjedde A, 2010, P NATL ACAD SCI USA, V107, P3870, DOI 10.1073/pnas.0912319107
   Guarnieri DJ, 2012, BIOL PSYCHIAT, V71, P358, DOI 10.1016/j.biopsych.2011.06.028
   Gubner NR, 2010, ALCOHOL CLIN EXP RES, V34, P1353, DOI 10.1111/j.1530-0277.2010.01219.x
   Hadad NA, 2014, PSYCHOPHARMACOLOGY, V231, P1897, DOI 10.1007/s00213-014-3461-1
   Hagan MM, 2003, INT J EAT DISORDER, V34, P183, DOI 10.1002/eat.10168
   Halpern CH, 2013, J NEUROSCI, V33, P7122, DOI 10.1523/JNEUROSCI.3237-12.2013
   Heyne A, 2009, ADDICT BIOL, V14, P373, DOI 10.1111/j.1369-1600.2009.00175.x
   Hoebel BG, 2009, J ADDICT MED, V3, P33, DOI 10.1097/ADM.0b013e31819aa621
   Ifland JR, 2009, MED HYPOTHESES, V72, P518, DOI 10.1016/j.mehy.2008.11.035
   Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519
   Kalra SP, 2004, J ADDICT DIS, V23, P5, DOI 10.1300/J069v23n03_02
   Latagliata EC, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-15
   Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698
   Olsen CM, 2011, NEUROPHARMACOLOGY, V61, P1109, DOI 10.1016/j.neuropharm.2011.03.010
   Orsini C, 2005, PSYCHOPHARMACOLOGY, V181, P327, DOI 10.1007/s000213-005-2259-6
   Orsini C, 2008, PSYCHOPHARMACOLOGY, V198, P287, DOI 10.1007/s00213-008-1137-4
   Oswald KD, 2011, INT J EAT DISORDER, V44, P203, DOI 10.1002/eat.20808
   Parker G, 2006, J AFFECT DISORDERS, V92, P149, DOI 10.1016/j.jad.2006.02.007
   Parylak SL, 2011, PHYSIOL BEHAV, V104, P149, DOI 10.1016/j.physbeh.2011.04.063
   Patel S, 2006, BEHAV BRAIN RES, V170, P197, DOI 10.1016/j.bbr.2006.02.019
   Petrovich GD, 2007, J NEUROSCI, V27, P6436, DOI 10.1523/JNEUROSCI.5001-06.2007
   Puglisi-Allegra S, 2000, NEUROREPORT, V11, P1361, DOI 10.1097/00001756-200004270-00042
   Puglisi-Allegra S, 2012, REV NEUROSCIENCE, V23, P509, DOI 10.1515/revneuro-2012-0076
   Puglisi-Allegra S, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00031
   PuglisiAllegra S, 1997, PROG NEUROBIOL, V51, P637, DOI 10.1016/S0301-0082(97)00008-7
   Rogers PJ, 2000, PHARMACOL BIOCHEM BE, V66, P3, DOI 10.1016/S0091-3057(00)00197-0
   Rolls ET, 2008, ACTA PHYSIOL HUNG, V95, P131, DOI 10.1556/APhysiol.95.2008.2.1
   ROUGEPONT F, 1995, J NEUROSCI, V15, P7189
   Rutter M, 2008, J ABNORM CHILD PSYCH, V36, P969, DOI 10.1007/s10802-008-9256-2
   Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P461, DOI 10.1007/s00213-006-0668-9
   Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021
   Sara SJ, 2012, NEURON, V76, P130, DOI 10.1016/j.neuron.2012.09.011
   Schroeder BE, 2001, NEUROSCIENCE, V105, P535, DOI 10.1016/S0306-4522(01)00221-4
   Solecki W, 2009, PSYCHOPHARMACOLOGY, V207, P245, DOI 10.1007/s00213-009-1672-7
   Stelzel C, 2010, J NEUROSCI, V30, P14205, DOI 10.1523/JNEUROSCI.1062-10.2010
   Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550
   Stice E, 2011, CURR TOP BEHAV NEURO, V6, P81, DOI 10.1007/7854_2010_89
   Stice E, 2010, J NEUROSCI, V30, P13105, DOI 10.1523/JNEUROSCI.2105-10.2010
   Szklarczyk K, 2012, GENES BRAIN BEHAV, V11, P977, DOI 10.1111/j.1601-183X.2012.00850.x
   Teegarden SL, 2008, PHYSIOL BEHAV, V93, P713, DOI 10.1016/j.physbeh.2007.11.030
   Tomer R, 2008, BIOL PSYCHOL, V77, P98, DOI 10.1016/j.biopsycho.2007.08.001
   Trifilieff P, 2013, MOL PSYCHIATR, V18, P1025, DOI 10.1038/mp.2013.57
   Trifilieff P, 2014, NEUROPHARMACOLOGY, V76, P498, DOI 10.1016/j.neuropharm.2013.06.031
   Usiello A, 2000, NATURE, V408, P199
   van den Bos R, 2006, BEHAV BRAIN RES, V171, P350, DOI 10.1016/j.bbr.2006.03.035
   van der Veen R, 2007, PSYCHOPHARMACOLOGY, V193, P179, DOI 10.1007/s00213-007-0777-0
   Ventura R, 2007, P NATL ACAD SCI USA, V104, P5181, DOI 10.1073/pnas.0610178104
   Volkow N, 2005, NAT NEUROSCI, V8, P1429, DOI 10.1038/nn1105-1429
   Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x
   Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022
   Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533
   Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452
   Volkow ND, 2008, PHILOS T R SOC B, V363, P3191, DOI 10.1098/rstb.2008.0107
   Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002
   Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001
   Wang GJ, 2009, J ADDICT MED, V3, P8, DOI 10.1097/ADM.0b013e31819a86f7
   Wang GJ, 2004, J ADDICT DIS, V23, P39, DOI 10.1300/J069v23n03_04
   Ward RD, 2012, NEUROPSYCHOPHARMACOL, V37, P1699, DOI 10.1038/npp.2012.15
   Weinshenker D, 2007, NEUROPSYCHOPHARMACOL, V32, P1433, DOI 10.1038/sj.npp.1301263
   Young JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004227
   Zhang XY, 2005, BIOL PSYCHIAT, V57, P1202, DOI 10.1016/j.biopsych.2005.02.003
NR 98
TC 9
Z9 9
U1 0
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 17
PY 2015
VL 10
IS 3
AR e0120191
DI 10.1371/journal.pone.0120191
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CD7QC
UT WOS:000351284600137
PM 25781028
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Vrijsen, JN
   Speckens, A
   Arias-Vasquez, A
   Franke, B
   Becker, ES
   van Oostrom, I
AF Vrijsen, Janna N.
   Speckens, Anne
   Arias-Vasquez, Alejandro
   Franke, Barbara
   Becker, Eni S.
   van Oostrom, Iris
TI No Evidence for the Association between a Polymorphism in the PCLO
   Depression Candidate Gene with Memory Bias in Remitted Depressed
   Patients and Healthy Individuals
SO PLOS ONE
LA English
DT Article
ID STRUCTURED CLINICAL INTERVIEW; SEROTONIN TRANSPORTER GENE; GENOME-WIDE
   ASSOCIATION; COGNITIVE VULNERABILITY; MAJOR DEPRESSION; EMOTIONAL FACES;
   LIFE EVENTS; DISORDER; ATTENTION; MOOD
AB The PCLO rs2522833 candidate polymorphism for depression has been associated to monoaminergic neurotransmission. In healthy and currently depressed individuals, the polymorphism has been found to affect activation of brain areas during memory processing, but no direct association of PCLO with memory bias was found. We hypothesized that the absence of this association might have been obscured by current depressive symptoms or genetically driven individual differences in reactivity to stressful events. Experiencing stressful childhood events fosters dysfunctional assumptions that are related to cognitive biases, and may modulate the predisposition for depression via epigenetic effects. The association between PCLO and memory bias, as well as interaction between PCLO and childhood events was studied in patients remitted from depression (N = 299), as well as a sample of healthy individuals (N = 157). The participants performed an emotional verbal memory task after a sad mood induction. Childhood trauma and adversity were measured with a questionnaire. The Genotype main effect, and Genotype by Childhood Events interaction were analyzed for memory bias in both samples. PCLO risk allele carrying remitted depressed patients did not show more negatively biased memory than non-risk allele carriers, not even patients with stressful childhood events. A similar pattern of results was found in healthy individuals. Memory bias may not be strongly associated with the PCLO rs2522833 polymorphism. We did not find any support for the PCLO-childhood events interaction, but the power of our study was insufficient to exclude this possibility.
C1 [Vrijsen, Janna N.; Speckens, Anne; Arias-Vasquez, Alejandro; Franke, Barbara; van Oostrom, Iris] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands.
   [Arias-Vasquez, Alejandro; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.
   [Arias-Vasquez, Alejandro] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands.
   [Arias-Vasquez, Alejandro; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.
   [Becker, Eni S.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.
RP Vrijsen, JN (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands.
EM Janna.Vrijsen@radboudumc.nl
RI Oostrom, I./L-4559-2015; Arias Vasquez, A./L-4175-2015; Franke,
   Barbara/D-4836-2009; Becker, Eni S/A-2668-2010; Vrijsen,
   Janna/L-4736-2015; Arias Vasquez, Alejandro/E-4762-2012; Speckens,
   Anne/H-8093-2014
OI Franke, Barbara/0000-0003-4375-6572; Becker, Eni S/0000-0003-3524-426X;
   Vrijsen, Janna/0000-0002-7081-9893; Arias Vasquez,
   Alejandro/0000-0002-4786-0169; Speckens, Anne/0000-0001-5266-1554
FU department of Psychiatry of the Radboud University Medical Centre
FX The study was funded by the department of Psychiatry of the Radboud
   University Medical Centre. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   Aragam N, 2011, J AFFECT DISORDERS, V133, P516, DOI 10.1016/j.jad.2011.04.054
   Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721
   Beck AT, 1996, BECK DEPRESSION INVE
   Betts M. J., 2007, BIOINFORMATICS GENET, P289
   Bhagwagar Z, 2007, PSYCHOL MED, V38, P307
   Bochdanovits Z, 2009, MOL PSYCHIATR, V14, P650, DOI 10.1038/mp.2009.37
   Bockting CLH, 2006, J CLIN PSYCHIAT, V67, P747, DOI 10.4088/JCP.v67n0508
   BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129
   Bradley M. M., 1999, C1 U FLOR CTR RES PS
   BREWIN CR, 1993, PSYCHOL BULL, V113, P82, DOI 10.1037//0033-2909.113.1.82
   BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925
   Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452
   De Raedt R, 2010, COGN AFFECT BEHAV NE, V10, P50, DOI 10.3758/CABN.10.1.50
   DENNY EB, 1992, J ABNORM PSYCHOL, V101, P575, DOI 10.1037/0021-843X.101.3.575
   Ellwart T, 2003, DEPRESS ANXIETY, V17, P197, DOI 10.1002/da.10102
   Firk C, 2007, J PSYCHOPHARMACOL, V21, P538, DOI 10.1177/0269881106075588
   First MB, 1996, STRUCTURED CLIN INTE
   Fitzgerald DA, 2011, NEUROIMAGE, V56, P1783, DOI 10.1016/j.neuroimage.2011.02.061
   Fox E, 2009, P R SOC B, V276, P1747, DOI 10.1098/rspb.2008.1788
   Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4
   Gerritsen L, 2011, MOL PSYCHIATR, V17, P597
   Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305
   Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P386, DOI 10.1037/0021-843x.113.3.386
   Gupta Rashmi, 2012, Front Psychiatry, V3, P99, DOI 10.3389/fpsyt.2012.00099
   Hek K, 2010, HUM MOL GENET, V19, P731, DOI 10.1093/hmg/ddp529
   Joormann J, 2007, J ABNORM PSYCHOL, V116, P80, DOI 10.1037/0021-843X.116.1.80
   Kanai T, 2003, PSYCHOL MED, V33, P839, DOI 10.1017/S0033291703007827
   Kendler KS, 2010, MOL PSYCHIATR, V15, P789, DOI 10.1038/mp.2010.8
   Klein AA, 2013, ADDICT BEHAV, V38, P1687, DOI 10.1016/j.addbeh.2012.10.006
   Kuehner C, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.11
   LeMoult J, 2012, COGNITIVE THER RES, V36, P47, DOI 10.1007/s10608-010-9322-2
   Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916
   MATT GE, 1992, CLIN PSYCHOL REV, V12, P227, DOI 10.1016/0272-7358(92)90116-P
   McCabe SB, 2000, COGNITIVE THER RES, V24, P427, DOI 10.1023/A:1005579719849
   Minelli A, 2012, J AFFECT DISORDERS, V139, P250, DOI 10.1016/j.jad.2012.01.028
   Pergamin-Hight L, 2012, BIOL PSYCHIAT, V71, P373, DOI 10.1016/j.biopsych.2011.10.030
   Perry BD, 1995, INFANT MENT HEALTH J, V16, P271, DOI 10.1002/1097-0355(199524)16:4<271::AID-IMHJ2280160404>3.0.CO;2-B
   Phaf RH, 2006, TECHNICAL REPORT
   Raven J. C., 1958, STANDARD PROGR MATRI
   Ridout N, 2009, BEHAV RES THER, V47, P851, DOI 10.1016/j.brat.2009.06.013
   ROGERS TB, 1977, J PERS SOC PSYCHOL, V35, P677, DOI 10.1037/0022-3514.35.9.677
   Schott BH, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.10
   Schuhmacher A, 2011, INT J NEUROPSYCHOPH, V14, P237, DOI 10.1017/S1461145710000854
   Shyn SI, 2010, PSYCHIAT CLIN N AM, V33, P125, DOI 10.1016/j.psc.2009.10.004
   SKRE I, 1991, ACTA PSYCHIAT SCAND, V84, P167, DOI 10.1111/j.1600-0447.1991.tb03123.x
   Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125
   Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552
   Teasdale JD, 1988, COGNITION EMOTION, V2, P247, DOI 10.1080/02699938808410927
   van Oostrom I, 2012, BIOL PSYCHOL, V89, P214, DOI 10.1016/j.biopsycho.2011.10.012
   van Tol MJ, 2012, BIOL PSYCHIAT, V71, P593, DOI 10.1016/j.biopsych.2011.11.016
   Verbeek EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079921
   Vogel S, 2014, PSYCHONEUROENDOCRINO, V40, P181, DOI 10.1016/j.psyneuen.2013.11.010
   Vrijsen JN, 2014, GENES BRAIN BEHAV, V13, P508, DOI 10.1111/gbb.12129
   Vrijsen JN, 2014, COGNITIVE THER RES, V38, P334, DOI 10.1007/s10608-013-9590-8
   Vrijsen JN, 2014, PSYCHIAT RES, V217, P134, DOI 10.1016/j.psychres.2014.02.033
   WATKINS PC, 1992, J ABNORM PSYCHOL, V101, P581, DOI 10.1037/0021-843X.101.3.581
   Watson DE, 2005, INT J TOXICOL, V24, P139, DOI 10.1080/10915810590948299
   Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122
   WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630
   WILLIAMS JMG, 1996, REMEMBERING OUR STUD
   Williams LM, 2010, NEUROIMAGE, V53, P918, DOI 10.1016/j.neuroimage.2010.01.084
   Wingenfeld K, 2013, PSYCHOPATHOLOGY, V46, P22, DOI 10.1159/000338609
   Woudstra S, 2012, TRANSL PSYCHIAT, V2, pe99
   Woudstra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061494
NR 67
TC 0
Z9 0
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 7
PY 2014
VL 9
IS 11
AR e112153
DI 10.1371/journal.pone.0112153
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AT3WF
UT WOS:000344863100057
PM 25379724
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Turner, KM
   Burne, THJ
AF Turner, Karly M.
   Burne, Thomas H. J.
TI Comprehensive Behavioural Analysis of Long Evans and Sprague-Dawley Rats
   Reveals Differential Effects of Housing Conditions on Tests Relevant to
   Neuropsychiatric Disorders
SO PLOS ONE
LA English
DT Article
ID GENE-ENVIRONMENT INTERACTIONS; VITAMIN-D DEFICIENCY; ELEVATED PLUS-MAZE;
   MOUSE MODELS; PREPULSE INHIBITION; STARTLE RESPONSE; KNOCKOUT MICE;
   SCHIZOPHRENIA; ENRICHMENT; STRAINS
AB Genetic (G) and environmental (E) manipulations are known to alter behavioural outcomes in rodents, however many animal models of neuropsychiatric disorders only use a restricted selection of strain and housing conditions. The aim of this study was to examine GxE interactions comparing two outbred rat strains, which were housed in either standard or enriched cages. The strains selected were the albino Sprague-Dawley rat, commonly used for animal models, and the other was the pigmented Long Evans rat, which is frequently used in cognitive studies. Rats were assessed using a comprehensive behavioural test battery and included well-established tests frequently employed to examine animal models of neuropsychiatric diseases, measuring aspects of anxiety, exploration, sensorimotor gating and cognition. Selective strain and housing effects were observed on a number of tests. These included increased locomotion and reduced pre-pulse inhibition in Long Evans rats compared to Sprague Dawley rats; and rats housed in enriched cages had reduced anxiety-like behaviour compared to standard housed rats. Long Evans rats required fewer sessions than Sprague Dawley rats to learn operant tasks, including a signal detection task and reversal learning. Furthermore, Long Evans rats housed in enriched cages acquired simple operant tasks faster than standard housed Long Evans rats. Cognitive phenotypes in animal models of neuropsychiatric disorders would benefit from using strain and housing conditions where there is greater potential for both enhancement and deficits in performance.
C1 [Turner, Karly M.; Burne, Thomas H. J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.
   [Burne, Thomas H. J.] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Wacol, Australia.
RP Burne, THJ (reprint author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.
EM t.burne@uq.edu.au
RI Turner, Karly/F-4607-2012; Burne, Thomas/C-5656-2009
OI Turner, Karly/0000-0003-3714-5118; Burne, Thomas/0000-0003-3502-9789
FU National Health and Medical Research Council of Australia [511066]
FX This work was supported by Project Grant no. 511066 from the National
   Health and Medical Research Council of Australia. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR ANDREWS JS, 1995, PHYSIOL BEHAV, V57, P785, DOI 10.1016/0031-9384(94)00336-X
   Andrews JS, 1996, COGNITIVE BRAIN RES, V3, P251, DOI 10.1016/0926-6410(96)00011-0
   Arrant AE, 2013, BEHAV BRAIN RES
   Aubert L, 2006, GENES BRAIN BEHAV, V5, P423, DOI 10.1111/j.1601-183X.2005.00178.x
   Bayer TA, 1999, J PSYCHIATR RES, V33, P543, DOI 10.1016/S0022-3956(99)00039-4
   Blokland A, 2012, BEHAV BRAIN RES, V228, P16, DOI 10.1016/j.bbr.2011.11.042
   Burghardt PR, 2004, BRAIN RES, V1019, P84, DOI 10.1016/j.brainres.2004.05.086
   Burne THJ, 2004, BEHAV BRAIN RES, V154, P549, DOI 10.1016/j.bbr.2004.03.023
   Burrows EL, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00157
   Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925
   Chen JS, 2006, BIOL PSYCHIAT, V59, P1180, DOI 10.1016/j.biopsych.2006.02.024
   Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589
   Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628
   Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X
   Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327
   DIDRIKSEN M, 1993, PHARMACOL TOXICOL, V72, P66, DOI 10.1111/j.1600-0773.1993.tb01341.x
   Duffy L, 2008, BEHAV NEUROSCI, V122, P748, DOI 10.1037/0735-7044.122.4.748
   Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598
   Faraday MM, 2002, PHYSIOL BEHAV, V75, P507, DOI 10.1016/S0031-9384(02)00645-5
   FILE SE, 1975, PSYCHOPHARMACOLOGIA, V44, P47, DOI 10.1007/BF00421183
   Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003
   Harris AP, 2009, ANIM BEHAV, V77, P1459, DOI 10.1016/j.anbehav.2009.02.019
   Henquet C, 2006, NEUROPSYCHOPHARMACOL, V31, P2748, DOI 10.1038/sj.npp.1301197
   Hutchinson E, 2005, ILAR J, V46, P148, DOI 10.1093/ilar.46.2.148
   Jones CA, 2011, BRIT J PHARMACOL, V164, P1162, DOI 10.1111/j.1476-5381.2011.01386.x
   Kalueff AV, 2005, J NEUROSCI METH, V143, P169, DOI 10.1016/j.jneumeth.2004.10.001
   Karl T, 2007, GENES BRAIN BEHAV, V6, P677, DOI 10.1111/j.1601-183X.2006.00298.x
   Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301
   Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023
   Kesby JP, 2012, PSYCHOPHARMACOLOGY, V220, P455, DOI 10.1007/s00213-011-2492-0
   Laviola G, 2008, NEUROBIOL DIS, V31, P159, DOI 10.1016/j.nbd.2008.05.001
   LIPSKA BK, 1995, P NATL ACAD SCI USA, V92, P8906, DOI 10.1073/pnas.92.19.8906
   McOmish CE, 2008, MOL PSYCHIATR, V13, P661, DOI 10.1038/sj.mp.4002046
   Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030
   Nguyen HP, 2006, HUM MOL GENET, V15, P3177, DOI 10.1093/hmg/ddl394
   Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970
   O'Tuathaigh CMP, 2007, NEUROSCI BIOBEHAV R, V31, P60, DOI 10.1016/j.neubiorev.2006.04.002
   OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037//0097-7403.2.2.97
   Papaleo F, 2012, NEUROPHARMACOLOGY, V62, P1204, DOI 10.1016/j.neuropharm.2011.04.025
   PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7
   Pena Y, 2009, PSYCHONEUROENDOCRINO, V34, P1390, DOI 10.1016/j.psyneuen.2009.04.019
   Pietropaolo S, 2006, BEHAV NEUROSCI, V120, P787, DOI 10.1097/0735-7044.120.4.787
   Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X
   Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9
   Simpson J, 2011, BEHAV BRAIN RES, V222, P246, DOI 10.1016/j.bbr.2011.04.002
   Swerdlow NR, 2000, J NEUROSCI, V20, P4325
   Swerdlow NR, 1999, ANN NY ACAD SCI, V877, P202, DOI 10.1111/j.1749-6632.1999.tb09269.x
   Tost H, 2012, NAT MED, V18, P211, DOI 10.1038/nm.2671
   Turner KM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00097
   van den Buuse M, 2010, SCHIZOPHRENIA BULL, V36, P246, DOI 10.1093/schbul/sbp132
   van Os J, 2002, AM J EPIDEMIOL, V156, P319, DOI 10.1093/aje/kwf043
   van Os J, 2008, SCHIZOPHRENIA BULL, V34, P1066, DOI 10.1093/schbul/sbn117
   van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563
   van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558
   VARTY GB, 1994, J PSYCHOPHARMACOL, V8, P148, DOI 10.1177/026988119400800302
   Varty GB, 2000, BIOL PSYCHIAT, V47, P864, DOI 10.1016/S0006-3223(99)00269-3
   Wray NR, 2010, SCHIZOPHRENIA BULL, V36, P14, DOI 10.1093/schbul/sbp137
NR 57
TC 17
Z9 18
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 26
PY 2014
VL 9
IS 3
AR e93411
DI 10.1371/journal.pone.0093411
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AE0SR
UT WOS:000333677000142
PM 24671152
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Shan, L
   Schipper, P
   Nonkes, LJP
   Homberg, JR
AF Shan, Ling
   Schipper, Pieter
   Nonkes, Lourens J. P.
   Homberg, Judith R.
TI Impaired Fear Extinction as Displayed by Serotonin Transporter Knockout
   Rats Housed in Open Cages Is Disrupted by IVC Cage Housing
SO PLOS ONE
LA English
DT Article
ID STRESS; ENVIRONMENT; BEHAVIOR; GENE; MICE; GENOTYPE; TESTS
AB Anxiety disorders are influenced by both environmental and genetic factors. A well-known example for gene x environment interactions in psychiatry is the low activity (s) allelic variant of the serotonin transporter (5-HTT) promoter polymorphism (5-HTTLPR) that in the context of stress increases risk for depression and post-traumatic stress disorder (PTSD). Previously, we observed robust anxiety-related phenotypes, such as an impairment in fear extinction, in 5-HTT knockout (5-HTT-/-) versus wild-type (5-HTT+/+) rats housed in open cages. Recently, housing conditions were changed from open cages to individually ventilated cages (IVC), which are associated with a high ventilation fold and noise. This switch in housing conditions prompted an unplanned 5-HTT gene x environment interaction study in our rats. The current study shows that lifetime stress by means of IVC cage housing abolished genotype differences in fear extinction between 5-HTT-/- and 5-HTT+/+ rats. Although this effect was not attributed specifically to either the 5-HTT+/+ or the 5-HTT-/- genotype, the findings are in agreement with the modulatory role of serotonin in the processing of environmental stimuli. Our findings also underline the possibility that housing conditions confound the interpretation of anxiety-related behaviours in rodents.
C1 [Shan, Ling; Schipper, Pieter; Nonkes, Lourens J. P.; Homberg, Judith R.] Radboud Univ Nijmegen, Med Ctr, Ctr Neurosci, Donders Inst Brain Cognit & Behaviour,Dept Cognit, NL-6525 ED Nijmegen, Netherlands.
RP Homberg, JR (reprint author), Radboud Univ Nijmegen, Med Ctr, Ctr Neurosci, Donders Inst Brain Cognit & Behaviour,Dept Cognit, NL-6525 ED Nijmegen, Netherlands.
EM Judith.Homberg@radboudumc.nl
RI Homberg, J.R./N-4172-2019; Shan, Ling/E-4281-2012; Shan,
   Ling/N-7075-2019; Homberg, Judith/D-2473-2010
OI Shan, Ling/0000-0002-4765-2474; Shan, Ling/0000-0002-4765-2474; 
FU Netherlands Organization for Scientific Research (NWO) [864.10.003]
FX This work was supported by the Netherlands Organization for Scientific
   Research (NWO), grant #864.10.003 awarded to J. R. Homberg. NWO had no
   further role in the design of the study, in the collection, analysis and
   interpretation of data.
CR Bilkei-Gorzo A, 2008, BEHAV BRAIN RES, V186, P289, DOI 10.1016/j.bbr.2007.08.027
   Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1
   Carroll JC, 2007, BEHAV GENET, V37, P214, DOI 10.1007/s10519-006-9129-9
   Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925
   Clement Y, 2002, BRAIN RES BULL, V57, P57, DOI 10.1016/S0361-9230(01)00637-2
   Heiming RS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.026.2009
   Homberg JR, 2007, NEUROSCIENCE, V146, P1662, DOI 10.1016/j.neuroscience.2007.03.030
   Homberg JR, 2012, PROG NEUROBIOL, V99, P117, DOI 10.1016/j.pneurobio.2012.08.003
   Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024
   Jansen F, 2010, BEHAV BRAIN RES, V207, P21, DOI 10.1016/j.bbr.2009.09.033
   Joeyen-Waldorf J, 2009, BRAIN RES, V1286, P84, DOI 10.1016/j.brainres.2009.06.079
   Kalueff AV, 2010, NEUROSCI BIOBEHAV R, V34, P373, DOI 10.1016/j.neubiorev.2009.08.003
   Lee HJ, 2005, DEPRESS ANXIETY, V21, P135, DOI 10.1002/da.20064
   Lewejohann L, 2006, GENES BRAIN BEHAV, V5, P64, DOI 10.1111/j.1601-183X.2005.00140.x
   Muller JM, 2011, GENES BRAIN BEHAV, V10, P166, DOI 10.1111/j.1601-183X.2010.00652.x
   Narayanan V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022600
   Nonkes LJP, 2012, J PSYCHIATR NEUROSCI, V37, P224, DOI 10.1503/jpn.110116
   Schipper P, 2011, BEHAV BRAIN RES, V223, P169, DOI 10.1016/j.bbr.2011.04.037
   Swaab DF, 2000, PROG BRAIN RES, V126, P369
   van der Doelen RHA, 2013, MOL PSYCHIATR, V18, P1244, DOI 10.1038/mp.2012.186
   Wahlsten D, 2006, P NATL ACAD SCI USA, V103, P16364, DOI 10.1073/pnas.0605342103
NR 21
TC 11
Z9 11
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 21
PY 2014
VL 9
IS 3
AR e91472
DI 10.1371/journal.pone.0091472
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AD6GL
UT WOS:000333355300034
PM 24658187
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Guo, LY
   Zhang, WN
   Chang, SH
   Zhang, LY
   Ott, J
   Wang, J
AF Guo, Liyuan
   Zhang, Weina
   Chang, Suhua
   Zhang, Liuyan
   Ott, Jurg
   Wang, Jing
TI MK4MDD: A Multi-Level Knowledge Base and Analysis Platform for Major
   Depressive Disorder
SO PLOS ONE
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; GENE-ENVIRONMENT INTERACTIONS;
   PSYCHIATRIC-DISORDERS; SCHIZOPHRENIA; EPIDEMIOLOGY; DATABASE; BRAIN;
   PSYCHOPATHOLOGY; NEUROBIOLOGY; POLYMORPHISM
AB Background: Major depressive disorder (MDD) is a complex neuropsychiatric syndrome with high heterogeneity. There are different levels of biological components that underlie MDD and interact with each other. To uncover the disease mechanism, large numbers of studies at different levels have been conducted. There is a growing need to integrate data from multiple levels of research into a database to provide a systematic review of current research results. The cross level integration will also help bridge gaps of different research levels for further understanding on MDD. So far, there has been no such effort for MDD.
   Descriptions: We offer researchers a Multi-level Knowledge base for MDD (MK4MDD) to study the interesting interplay of components in the pathophysiological cascade of MDD from genetic variations to diagnostic syndrome. MK4MDD contains 2,341 components and 5,206 relationships between components based on reported experimental results obtained by diligent literature reading with manual curation. All components were well classified with careful curation and supplementary annotation. The powerful search and visualization tools make all data in MK4MDD form a cross-linked network to be applied to a broad range of both basic and applied research.
   Conclusions: MK4MDD aims to provide researchers with a central knowledge base and analysis platform for MDD etiological and pathophysiological mechanisms research. MK4MDD is freely available at http://mdd.psych.ac.cn.
C1 [Guo, Liyuan; Zhang, Weina; Chang, Suhua; Zhang, Liuyan; Ott, Jurg; Wang, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.
   [Zhang, Weina; Zhang, Liuyan] Chinese Acad Sci, Grad Univ, Beijing 100101, Peoples R China.
RP Wang, J (reprint author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.
EM wangjing@psych.ac.cn
FU Key Laboratory of Mental Health, Institute of Psychology, Chinese
   Academy of Sciences; Scientific Foundation of Institute of Psychology,
   Chinese Academy of Sciences [Y0CX411S01]; NSFC [30730057]
FX This work was supported by Key Laboratory of Mental Health, Institute of
   Psychology, Chinese Academy of Sciences and the Scientific Foundation of
   Institute of Psychology, Chinese Academy of Sciences, No. Y0CX411S01
   (http://psych.ac.cn). Support by NSFC grant number 30730057 to JO is
   also acknowledged (http://www.nsfc.gov.cn). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171
   Allis C.D., 2007, EPIGENETICS
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Andreasen NC, 1997, SCIENCE, V275, P1586, DOI 10.1126/science.275.5306.1586
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989
   Avramopoulos D, 2010, PSYCHIAT CLIN N AM, V33, P1, DOI 10.1016/j.psc.2009.12.006
   Barsky E, 2007, J CAN HEALTH LIBRARI, V28, P147, DOI 10.5596/c07-036
   Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835
   Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1056/NEJMra073096
   Bosker FJ, 2011, MOL PSYCHIATR, V16, P516, DOI 10.1038/mp.2010.38
   Brendgen M, 2009, J CHILD PSYCHOL PSYC, V50, P1009, DOI 10.1111/j.1469-7610.2009.02052.x
   Cannon TD, 2006, ANNU REV CLIN PSYCHO, V2, P267, DOI 10.1146/annurev.clinpsy.2.022305.095232
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925
   Dai Q, 2009, PROG NEURO-PSYCHOPH, V33, P921, DOI 10.1016/j.pnpbp.2009.04.012
   Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064
   Frodl T, 2007, ARCH GEN PSYCHIAT, V64, P410, DOI 10.1001/archpsyc.64.4.410
   Gazzaniga M, 2009, COGNITIVE NEUROSCIEN
   Gelder M, 2011, NEW OXFORD TXB PSYCH
   Gelder M., 1999, PSYCHIATRY
   Gelder Michael, 1983, OXFORD TXB PSYCHIAT
   Glahn DC, 2007, HUM BRAIN MAPP, V28, P461, DOI 10.1002/hbm.20416
   Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636
   GOTTESMAN II, 1973, BRIT J PSYCHIAT, V122, P15, DOI 10.1192/bjp.122.1.15
   Handy T., 2005, EVENT RELATED POTENT
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Hyde LW, 2011, TRENDS COGN SCI, V15, P417, DOI 10.1016/j.tics.2011.07.001
   Jia P, 2010, MOL PSYCHIATR, V15, P453, DOI 10.1038/mp.2009.93
   Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102
   Kao CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018696
   Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095
   Kohli MA, 2011, NEURON, V70, P252, DOI 10.1016/j.neuron.2011.04.005
   Konneker T, 2008, AM J MED GENET B, V147B, P671, DOI 10.1002/ajmg.b.30802
   Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455
   Lewis CM, 2010, AM J PSYCHIAT, V167, P949, DOI 10.1176/appi.ajp.2010.09091380
   Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430
   Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009
   Middeldorp CM, 2008, PSYCHOL MED, V38, P1557, DOI 10.1017/S0033291708002985
   Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740
   Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0
   Pfleiderer B, 2003, PSYCHIAT RES-NEUROIM, V122, P185, DOI 10.1016/S0925-4927(03)00003-9
   Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892
   Rietschel M, 2010, BIOL PSYCHIAT, V68, P578, DOI 10.1016/j.biopsych.2010.05.038
   Sabb FW, 2008, MOL PSYCHIATR, V13, P350, DOI 10.1038/sj.mp.4002124
   Savitz JB, 2009, NEUROSCIENCE, V164, P300, DOI 10.1016/j.neuroscience.2009.03.082
   Scarabino T, 2006, ATLAS MORPHOLOGY FUN
   Schmidt MV, 2011, PSYCHONEUROENDOCRINO, V36, P330, DOI 10.1016/j.psyneuen.2010.07.001
   Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892
   Segman RH, 2010, MOL PSYCHIATR, V15, P93, DOI 10.1038/mp.2009.65
   Senior C. T., 2006, METHODS MIND
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124
   Shyn SI, 2011, MOL PSYCHIATR, V16, P202, DOI 10.1038/mp.2009.125
   Spijker S, 2010, BIOL PSYCHIAT, V68, P179, DOI 10.1016/j.biopsych.2010.03.017
   Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125
   Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552
   Tollefsbol TO, 2011, HANDBOOK OF EPIGENETICS: THE NEW MOLECULAR AND MEDICAL GENETICS, P1, DOI 10.1016/B978-0-12-375709-8.00001-0
   Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39
   Wong ML, 2008, MOL PSYCHIATR, V13, P800, DOI 10.1038/mp.2008.59
   Wray NR, 2012, MOL PSYCHIATR, V17, P36, DOI 10.1038/mp.2010.109
   Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124
   Zhang L, 2011, NUCLEIC ACIDS RES, V40, pD1003
NR 64
TC 7
Z9 7
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 5
PY 2012
VL 7
IS 10
AR e46335
DI 10.1371/journal.pone.0046335
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 020QD
UT WOS:000309827300021
PM 23071556
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Narayanan, V
   Heiming, RS
   Jansen, F
   Lesting, J
   Sachser, N
   Pape, HC
   Seidenbecher, T
AF Narayanan, Venu
   Heiming, Rebecca S.
   Jansen, Friederike
   Lesting, Joerg
   Sachser, Norbert
   Pape, Hans-Christian
   Seidenbecher, Thomas
TI Social Defeat: Impact on Fear Extinction and Amygdala-Prefrontal
   Cortical Theta Synchrony in 5-HTT Deficient Mice
SO PLOS ONE
LA English
DT Article
ID SEROTONIN TRANSPORTER GENE; NUCLEUS RAPHE DORSALIS; ANXIETY-LIKE
   BEHAVIOR; IN-VIVO; BASOLATERAL AMYGDALA; BRAIN-SEROTONIN; MONOAMINE
   TRANSPORTERS; VENTRAL HIPPOCAMPUS; GABAERGIC NEURONS; LIFE STRESS
AB Emotions, such as fear and anxiety, can be modulated by both environmental and genetic factors. One genetic factor is for example the genetically encoded variation of the serotonin transporter (5-HTT) expression. In this context, the 5-HTT plays a key role in the regulation of central 5-HT neurotransmission, which is critically involved in the physiological regulation of emotions including fear and anxiety. However, a systematic study which examines the combined influence of environmental and genetic factors on fear-related behavior and the underlying neurophysiological basis is missing. Therefore, in this study we used the 5-HTT-deficient mouse model for studying emotional dysregulation to evaluate consequences of genotype specific disruption of 5-HTT function and repeated social defeat for fear-related behaviors and corresponding neurophysiological activities in the lateral amygdala (LA) and infralimbic region of the medial prefrontal cortex (mPFC) in male 5-HTT wild-type (+/+), homo-(-/-) and heterozygous (+/-) mice. Naive males and experienced losers (generated in a resident-intruder paradigm) of all three genotypes, unilaterally equipped with recording electrodes in LA and mPFC, underwent a Pavlovian fear conditioning. Fear memory and extinction of conditioned fear was examined while recording neuronal activity simultaneously with fear-related behavior. Compared to naive 5-HTT+/+ and +/- mice, 5-HTT-/- mice showed impaired recall of extinction. In addition, 5-HTT-/- and +/- experienced losers showed delayed extinction learning and impaired recall of extinction. Impaired behavioral responses were accompanied by increased theta synchronization between the LA and mPFC during extinction learning in 5-HTT-/- and +/- losers. Furthermore, impaired extinction recall was accompanied with increased theta synchronization in 5-HTT-/- naive and in 5-HTT-/- and +/- loser mice. In conclusion, extinction learning and memory of conditioned fear can be modulated by both the 5-HTT gene activity and social experiences in adulthood, accompanied by corresponding alterations of the theta activity in the amygdala-prefrontal cortex network.
C1 [Narayanan, Venu; Lesting, Joerg; Pape, Hans-Christian; Seidenbecher, Thomas] Univ Munster, Inst Physiol 1, Munster, Germany.
   [Heiming, Rebecca S.; Jansen, Friederike; Sachser, Norbert] Univ Munster, Dept Behav Biol, Munster, Germany.
   [Heiming, Rebecca S.; Sachser, Norbert] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, Munster, Germany.
RP Narayanan, V (reprint author), Univ Munster, Inst Physiol 1, Munster, Germany.
EM seidenbe@uni-muenster.de
FU German Science Foundation (DFG) [SFB-TRR58, TP A01, A02]
FX This work was supported by the German Science Foundation (DFG,
   SFB-TRR58, TP A01; to N. Sachser, K-P. Lesch and T. Seidenbecher and A02
   to TS and HCP). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Adhikari A, 2010, J NEUROSCI METH, V191, P191, DOI 10.1016/j.jneumeth.2010.06.019
   Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002
   *AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P424
   Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678
   Arango V, 2001, NEUROPSYCHOPHARMACOL, V25, P892, DOI 10.1016/S0893-133X(01)00310-4
   Ballenger JC, 1999, BIOL PSYCHIAT, V46, P1579, DOI 10.1016/S0006-3223(99)00220-6
   Barr CS, 2004, P NATL ACAD SCI USA, V101, P12358, DOI 10.1073/pnas.0403763101
   Bartolomucci A, 2010, DIS MODEL MECH, V3, P459, DOI 10.1242/dmm.004614
   Bengel D, 1998, MOL PHARMACOL, V53, P649
   BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0
   BRILEY MS, 1980, NEUROPHARMACOLOGY, V19, P1209, DOI 10.1016/0028-3908(80)90204-X
   Buwalda B, 2005, NEUROSCI BIOBEHAV R, V29, P83, DOI 10.1016/j.neubiorev.2004.05.005
   BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1
   Carroll JC, 2007, BEHAV GENET, V37, P214, DOI 10.1007/s10519-006-9129-9
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925
   Celada P, 2001, J NEUROSCI, V21, P9917, DOI 10.1523/JNEUROSCI.21-24-09917.2001
   Champagne FA, 2005, CURR OPIN NEUROBIOL, V15, P704, DOI 10.1016/j.conb.2005.10.001
   Clement Y, 2002, BRAIN RES BULL, V57, P57, DOI 10.1016/S0361-9230(01)00637-2
   Daws LC, 2006, J NEUROSCI, V26, P6431, DOI 10.1523/JNEUROSCI.4050-05.2006
   Fabre V, 2000, EUR J NEUROSCI, V12, P2299, DOI 10.1046/j.1460-9568.2000.00126.x
   FLUGGE G, 1995, J NEUROSCI, V15, P7132
   Franklin K.G.J., 1997, MOUSE BRAIN STEREOTA
   Gingrich JA, 2001, PSYCHOPHARMACOLOGY, V155, P1, DOI 10.1007/s002130000573
   Gobbi G, 2001, J PHARMACOL EXP THER, V296, P987
   Grace AA, 2002, PHYSIOL BEHAV, V77, P489, DOI 10.1016/S0031-9384(02)00909-5
   Gross C, 2004, NEUROTOX RES, V6, P493, DOI 10.1007/BF03033286
   Hajos M, 2003, NEUROPHARMACOLOGY, V45, P72, DOI 10.1016/S0028-3908(03)00139-4
   Hammack SE, 2009, PROG NEURO-PSYCHOPH, V33, P1309, DOI 10.1016/j.pnpbp.2009.05.013
   Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829
   Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146
   Heiming RS, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.026.2009
   Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366
   Holmes A, 2003, BIOL PSYCHIAT, V54, P953, DOI 10.1016/j.biopsych.2003.09.003
   Holmes A, 2002, NEUROPSYCHOPHARMACOL, V27, P914, DOI 10.1016/S0893-133X(02)00374-3
   Holmes A, 2001, NEUROSCI BIOBEHAV R, V25, P261, DOI 10.1016/S0149-7634(01)00012-4
   Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005
   Holmes Philip V., 2003, Critical Reviews in Neurobiology, V15, P143, DOI 10.1615/CritRevNeurobiol.v15.i2.30
   Jansen F, 2010, BEHAV BRAIN RES, V207, P21, DOI 10.1016/j.bbr.2009.09.033
   Jennings KA, 2006, J NEUROSCI, V26, P8955, DOI 10.1523/JNEUROSCI.5356-05.2006
   Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002
   Julius D, 1998, P NATL ACAD SCI USA, V95, P15153, DOI 10.1073/pnas.95.26.15153
   Kaiser S, 2005, NEUROSCI BIOBEHAV R, V29, P283, DOI 10.1016/j.neubiorev.2004.09.015
   Kim DK, 2005, NEUROPHARMACOLOGY, V49, P798, DOI 10.1016/j.neuropharm.2005.08.010
   Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8
   Koyama S, 1999, J PHYSIOL-LONDON, V518, P525, DOI 10.1111/j.1469-7793.1999.0525p.x
   Koyama S, 2002, LIFE SCI, V72, P375, DOI 10.1016/S0024-3205(02)02280-4
   Kugaya A, 2003, NEUROPSYCHOPHARMACOL, V28, P413, DOI 10.1038/sj.npp.1300036
   Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007
   Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527
   Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174
   Lesch KP, 1998, BIOL PSYCHIAT, V44, P179, DOI 10.1016/S0006-3223(98)00121-8
   Lesting J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021714
   Lesting J, 2011, EPILEPSIA, V52, P337, DOI 10.1111/j.1528-1167.2010.02758.x
   Li XB, 2001, EUR J PHARMACOL, V425, P43, DOI 10.1016/S0014-2999(01)01159-1
   Line SJ, 2011, EUR NEUROPSYCHOPHARM, V21, P108, DOI 10.1016/j.euroneuro.2010.08.005
   Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005
   Lucki I, 2004, J CLIN PSYCHIAT, V65, P11
   MA QP, 1991, NEUROSCI LETT, V134, P21, DOI 10.1016/0304-3940(91)90499-J
   Malison RT, 1998, BIOL PSYCHIAT, V44, P1090, DOI 10.1016/S0006-3223(98)00272-8
   Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535
   Marowsky A, 2005, NEURON, V48, P1025, DOI 10.1016/j.neuron.2005.10.029
   Marrosu F, 1996, BRAIN RES, V739, P192, DOI 10.1016/S0006-8993(96)00826-8
   MARU E, 1979, BRAIN RES, V163, P223, DOI 10.1016/0006-8993(79)90351-2
   Mathews TA, 2004, J NEUROSCI METH, V140, P169, DOI 10.1016/j.jneumeth.2004.05.017
   Mossner R, 1998, INT J NEUROPSYCHOP, V1, P87, DOI 10.1017/S1461145798001114
   Munafo MR, 2005, MOL PSYCHIATR, V10, P415, DOI 10.1038/sj.mp.4001627
   Murphy DL, 2001, BRAIN RES BULL, V56, P487, DOI 10.1016/S0361-9230(01)00622-0
   Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8
   Murphy DL, 1999, TRENDS PHARMACOL SCI, V20, P246, DOI 10.1016/S0165-6147(99)01325-5
   Narayanan RT, 2007, EUR J NEUROSCI, V25, P1823, DOI 10.1111/j.1460-9568.2007.05437.x
   Narayanan RT, 2007, NEUROREPORT, V18, P1107, DOI 10.1097/WNR.0b013e3282004992
   NEMEROFF CB, 1994, AM J PSYCHIAT, V151, P1623
   Neumeister A, 2002, ARCH GEN PSYCHIAT, V59, P613, DOI 10.1001/archpsyc.59.7.613
   Nietzer SL, 2011, BEHAV BRAIN RES, V220, P42, DOI 10.1016/j.bbr.2011.01.011
   Nitz DA, 1999, LEARN MEMORY, V6, P153
   Pape HC, 1998, J NEUROPHYSIOL, V79, P217
   Pape HC, 2005, NEURON, V48, P877, DOI 10.1016/j.neuron.2005.12.002
   PAPE HC, 2010, PHYSL REV IN PRESS
   PARE D, 1995, J NEUROPHYSIOL, V74, P1179
   Pare D, 2002, TRENDS COGN SCI, V6, P306, DOI 10.1016/S1364-6613(02)01924-1
   Pelletier JG, 2004, BIOL PSYCHIAT, V55, P559, DOI 10.1016/j.biopsych.2003.08.019
   Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463
   Pinto A, 2003, J COMP NEUROL, V459, P142, DOI 10.1002/cne.10596
   Puig MV, 2005, CEREB CORTEX, V15, P1, DOI 10.1093/cercor/bhh104
   Rainnie DG, 1999, J NEUROPHYSIOL, V82, P69
   Sangha S, 2009, J NEUROSCI, V29, P15713, DOI 10.1523/JNEUROSCI.2620-09.2009
   Savitz J, 2009, PROG NEUROBIOL, V88, P17, DOI 10.1016/j.pneurobio.2009.01.009
   Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818
   Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184
   Stein D.J, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002795
   STEINBUSCH HWM, 1981, J PHYSIOLOGY PARIS, V77, P157
   Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008
   Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002
   Veenema AH, 2007, PSYCHONEUROENDOCRINO, V32, P437, DOI 10.1016/j.psyneuen.2007.02.008
   VERTES RP, 1994, NEUROSCIENCE, V60, P441, DOI 10.1016/0306-4522(94)90255-0
   Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007
   Willeit M, 2000, BIOL PSYCHIAT, V47, P482, DOI 10.1016/S0006-3223(99)00293-0
   Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9
NR 99
TC 65
Z9 66
U1 0
U2 21
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 27
PY 2011
VL 6
IS 7
AR e22600
DI 10.1371/journal.pone.0022600
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 799JJ
UT WOS:000293282700045
PM 21818344
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Chen, CH
   Chen, CS
   Moyzis, R
   Stern, H
   He, QH
   Li, H
   Li, J
   Zhu, B
   Dong, Q
AF Chen, Chunhui
   Chen, Chuansheng
   Moyzis, Robert
   Stern, Hal
   He, Qinghua
   Li, He
   Li, Jin
   Zhu, Bi
   Dong, Qi
TI Contributions of Dopamine-Related Genes and Environmental Factors to
   Highly Sensitive Personality: A Multi-Step Neuronal System-Level
   Approach
SO PLOS ONE
LA English
DT Article
ID CATECHOL-O-METHYLTRANSFERASE; GENOME-WIDE ASSOCIATION; DEFICIT
   HYPERACTIVITY DISORDER; SENSORY-PROCESSING SENSITIVITY; CHINESE HAN
   POPULATION; VAL158MET POLYMORPHISM; MONOAMINE-OXIDASE; KOREAN
   POPULATION; CANDIDATE GENES; NOVELTY SEEKING
AB Traditional behavioral genetic studies (e. g., twin, adoption studies) have shown that human personality has moderate to high heritability, but recent molecular behavioral genetic studies have failed to identify quantitative trait loci (QTL) with consistent effects. The current study adopted a multi-step approach (ANOVA followed by multiple regression and permutation) to assess the cumulative effects of multiple QTLs. Using a system-level (dopamine system) genetic approach, we investigated a personality trait deeply rooted in the nervous system (the Highly Sensitive Personality, HSP). 480 healthy Chinese college students were given the HSP scale and genotyped for 98 representative polymorphisms in all major dopamine neurotransmitter genes. In addition, two environment factors (stressful life events and parental warmth) that have been implicated for their contributions to personality development were included to investigate their relative contributions as compared to genetic factors. In Step 1, using ANOVA, we identified 10 polymorphisms that made statistically significant contributions to HSP. In Step 2, these polymorphism's main effects and interactions were assessed using multiple regression. This model accounted for 15% of the variance of HSP (p < 0.001). Recent stressful life events accounted for an additional 2% of the variance. Finally, permutation analyses ascertained the probability of obtaining these findings by chance to be very low, p ranging from 0.001 to 0.006. Dividing these loci by the subsystems of dopamine synthesis, degradation/transport, receptor and modulation, we found that the modulation and receptor subsystems made the most significant contribution to HSP. The results of this study demonstrate the utility of a multi-step neuronal system-level approach in assessing genetic contributions to individual differences in human behavior. It can potentially bridge the gap between the high heritability estimates based on traditional behavioral genetics and the lack of reproducible genetic effects observed currently from molecular genetic studies.
C1 [Chen, Chunhui; Li, Jin; Zhu, Bi; Dong, Qi] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.
   [Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA.
   [Moyzis, Robert] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA.
   [Moyzis, Robert] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA USA.
   [Stern, Hal] Univ Calif Irvine, Dept Stat, Irvine, CA USA.
   [He, Qinghua] Univ So Calif, Brain & Creat Inst, Los Angeles, CA USA.
   [Li, He] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China.
RP Chen, CH (reprint author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.
EM dongqi@bnu.edu.cn
OI He, Qinghua/0000-0001-6396-6273; Chen, Chuansheng/0000-0002-8224-1005
FU 111 Project [B07008]; Ministry of Education of China [10YJCXLX032]
FX This study was supported by the 111 Project (B07008) and the project for
   young people who are devoted to the researches of humanities and social
   sciences (10YJCXLX032) of the Ministry of Education of China. The funder
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116
   Aron A, 2010, SOC COGN AFFECT NEUR, V5, P219, DOI 10.1093/scan/nsq028
   Aron EN, 1997, J PERS SOC PSYCHOL, V73, P345, DOI 10.1037/0022-3514.73.2.345
   Aron EN, 2005, PERS SOC PSYCHOL B, V31, P181, DOI 10.1177/0146167204271419
   Austin J, 2000, MOL PSYCHIATR, V5, P552, DOI 10.1038/sj.mp.4000761
   Benham G, 2006, PERS INDIV DIFFER, V40, P1433, DOI 10.1016/j.paid.2005.11.021
   BOUCHARD TJ, 1994, SCIENCE, V264, P1700, DOI 10.1126/science.8209250
   Boules M, 2007, CNS DRUGS, V21, P13, DOI 10.2165/00023210-200721010-00002
   Caceda R, 2006, PEPTIDES, V27, P2385, DOI 10.1016/j.peptides.2006.04.024
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Caspi A, 2002, SCIENCE, V297, P851, DOI 10.1126/science.1072290
   Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925
   CHEN C, ADDICTION B IN PRESS
   Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001
   COMPAS BE, 1987, CLIN PSYCHOL REV, V7, P275, DOI 10.1016/0272-7358(87)90037-7
   Depue RA, 1999, BEHAV BRAIN SCI, V22, P491
   Derringer J, 2010, PSYCHOL SCI, V21, P1282, DOI 10.1177/0956797610380699
   Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099
   Distel MA, 2008, PSYCHOL MED, V38, P1219, DOI 10.1017/S0033291707002024
   Distel MA, 2008, PSYCHIAT GENET, V18, P302, DOI 10.1097/YPG.0b013e3283118468
   Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78
   Enoch MA, 2003, PSYCHIAT GENET, V13, P33, DOI 10.1097/01.ypg.0000054709.85338.c3
   Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258
   Gillespie NA, 2008, J PERS, V76, P1415, DOI 10.1111/j.1467-6494.2008.00527.x
   Gonda X, 2009, EUR ARCH PSY CLIN N, V259, P106, DOI 10.1007/s00406-008-0842-7
   Greenberger E, 2000, J CONSULT CLIN PSYCH, V68, P209, DOI 10.1037//0022-006X.68.2.209
   Gregory AM, 2009, DEVELOPMENTAL SCI, V12, P165, DOI 10.1111/j.1467-7687.2008.00739.x
   Gu DF, 2006, HYPERTENSION, V47, P1147, DOI 10.1161/01.HYP.0000219041.66702.45
   Guan L, 2009, MOL PSYCHIATR, V14, P546, DOI 10.1038/sj.mp.4002139
   Ham BJ, 2004, NEUROSCI LETT, V354, P2, DOI 10.1016/S0304-3940(03)00753-5
   Hashimoto R, 2007, NEUROSCI LETT, V428, P17, DOI 10.1016/j.neulet.2007.09.036
   Hawks J, 2007, P NATL ACAD SCI USA, V104, P20753, DOI 10.1073/pnas.0707650104
   Hong XM, 2009, CURR OPIN PEDIATR, V21, P770, DOI 10.1097/MOP.0b013e32833252dc
   Hosak L, 2006, NEUROENDOCRINOL LETT, V27, P799
   Isen J, 2009, BEHAV GENET, V39, P36, DOI 10.1007/s10519-008-9244-x
   Ishii G, 2007, EUR PSYCHIAT, V22, P462, DOI 10.1016/j.eurpsy.2007.05.005
   Ivorra-Martinez J, 2007, REV NEUROLOGIA, V45, P418, DOI 10.33588/rn.4507.2007247
   Jomphe C, 2006, EUR J NEUROSCI, V24, P2789, DOI 10.1111/j.1460-9568.2006.05151.x
   Kim SJ, 2006, NEUROSCI LETT, V401, P154, DOI 10.1016/j.neulet.2006.03.006
   Krueger RF, 2008, J PERS, V76, P1485, DOI 10.1111/j.1467-6494.2008.00529.x
   Lee HJ, 2003, AM J MED GENET B, V121B, P44, DOI 10.1002/ajmg.b.20054
   Light Katrina J, 2007, Behav Brain Funct, V3, P3, DOI 10.1186/1744-9081-3-3
   Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772
   Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494
   McCaffery JM, 2009, AM J CLIN NUTR, V89, P1011, DOI 10.3945/ajcn.2008.27170
   McGuffin P, 2001, SCIENCE, V291, P1232, DOI 10.1126/science.1057264
   Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713
   Murcray CE, 2009, AM J EPIDEMIOL, V169, P219, DOI 10.1093/aje/kwn353
   Nilsson KW, 2009, UPSALA J MED SCI, V114, P100, DOI 10.1080/03009730902833406
   Ohinata K, 2007, PEPTIDES, V28, P1470, DOI 10.1016/j.peptides.2007.06.002
   Plomin R, 2009, J CHILD PSYCHOL PSYC, V50, P63, DOI 10.1111/j.1469-7610.2008.01978.x
   Plomp E, 2009, NEUROSCIENCE, V164, P230, DOI 10.1016/j.neuroscience.2009.07.024
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Qian Q, 2004, AM J MED GENET B, V128B, P84, DOI 10.1002/ajmg.b.30079
   Qian QJ, 2003, AM J MED GENET B, V118B, P103, DOI 10.1002/ajmg.b.10064
   Ruchkin VV, 1998, COMPR PSYCHIAT, V39, P225, DOI 10.1016/S0010-440X(98)90065-7
   Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816
   Samochowiec J, 2000, Psychiatr Pol, V34, P99
   Shifman S, 2008, MOL PSYCHIATR, V13, P302, DOI 10.1038/sj.mp.4002048
   Smillie LD, 2010, NEUROSCI LETT, V468, P234, DOI 10.1016/j.neulet.2009.10.095
   St-Gelais F, 2006, J PSYCHIATR NEUROSCI, V31, P229
   Torgersen S, 2008, PSYCHOL MED, V38, P1617, DOI 10.1017/S0033291708002924
   Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854
   Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102
   Wang LY, 2008, CLIN SCI, V115, P151, DOI 10.1042/CS20070335
   Wermter AK, 2010, EUR CHILD ADOLES PSY, V19, P199, DOI 10.1007/s00787-009-0082-z
   WILLS TA, 1992, AM J COMMUN PSYCHOL, V20, P349, DOI 10.1007/BF00937914
   Wu J, 2010, GENET EPIDEMIOL, V34, P275, DOI 10.1002/gepi.20459
   Wu XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004578
   Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608
NR 70
TC 25
Z9 27
U1 1
U2 29
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 13
PY 2011
VL 6
IS 7
AR e21636
DI 10.1371/journal.pone.0021636
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 792WQ
UT WOS:000292781500006
PM 21765900
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Fortuna, K
   van IJzendoorn, MH
   Mankuta, D
   Kaitz, M
   Avinun, R
   Ebstein, RP
   Knafo, A
AF Fortuna, Keren
   van IJzendoorn, Marinus H.
   Mankuta, David
   Kaitz, Marsha
   Avinun, Reut
   Ebstein, Richard P.
   Knafo, Ariel
TI Differential Genetic Susceptibility to Child Risk at Birth in Predicting
   Observed Maternal Behavior
SO PLOS ONE
LA English
DT Article
ID PRETERM INFANTS; PARENTING STRESS; ENVIRONMENTAL-INFLUENCES;
   EXTERNALIZING BEHAVIOR; WEIGHT INFANT; MOTHER-CHILD; LIFE STRESS;
   POLYMORPHISM; TERM; DRD4
AB This study examined parenting as a function of child medical risks at birth and parental genotype (dopamine D4 receptor; DRD4). Our hypothesis was that the relation between child risks and later maternal sensitivity would depend on the presence/absence of a genetic variant in the mothers, thus revealing a gene by environment interaction (GXE). Risk at birth was defined by combining risk indices of children's gestational age at birth, birth weight, and admission to the neonatal intensive care unit. The DRD4-III 7-repeat allele was chosen as a relevant genotype as it was recently shown to moderate the effect of environmental stress on parental sensitivity. Mothers of 104 twin pairs provided DNA samples and were observed with their children in a laboratory play session when the children were 3.5 years old. Results indicate that higher levels of risk at birth were associated with less sensitive parenting only among mothers carrying the 7-repeat allele, but not among mothers carrying shorter alleles. Moreover, mothers who are carriers of the 7-repeat allele and whose children scored low on the risk index were observed to have the highest levels of sensitivity. These findings provide evidence for the interactive effects of genes and environment (in this study, children born at higher risk) on parenting, and are consistent with a genetic differential susceptibility model of parenting by demonstrating that some parents are inherently more susceptible to environmental influences, both good and bad, than are others.
C1 [Fortuna, Keren; Kaitz, Marsha; Ebstein, Richard P.; Knafo, Ariel] Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel.
   [van IJzendoorn, Marinus H.] Leiden Univ, Ctr Child & Family Studies, Leiden, Netherlands.
   [Mankuta, David] Hadassah Univ Hosp, Dept Obstet & Gynecol, IL-91120 Jerusalem, Israel.
   [Avinun, Reut] Hebrew Univ Jerusalem, Dept Neurobiol, Jerusalem, Israel.
   [Ebstein, Richard P.] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore.
RP Fortuna, K (reprint author), Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel.
EM keren.fortuna@mail.huji.ac.il
RI van IJzendoorn, Marinus/I-1379-2012; Knafo-Noam, Ariel/E-8067-2011; van
   IJzendoorn, Marinus/P-4907-2019
OI van IJzendoorn, Marinus/0000-0003-1144-454X; Knafo-Noam,
   Ariel/0000-0003-0613-1960; Avinun, Reut/0000-0002-3281-1268; Ebstein,
   Richard/0000-0002-3626-541X
FU Israel Science Foundation [31/06]; Science of Generosity Initiative;
   Center for the Study of Religion and Society; University of Notre Dame;
   European Research Council [240994]; Israel Ministry of Immigrant
   Absorption; Center for Absorption in Science
FX This study was supported in part by grant No. 31/06 from the Israel
   Science Foundation founded by the Israel Academy of Sciences and
   Humanities (AK). Preparation of this manuscript was supported by a grant
   from The Science of Generosity Initiative, Center for the Study of
   Religion and Society, University of Notre Dame (AK) and by a European
   Research Council Grant (Starting Grant no. 240994) to the last author
   (AK). KF is the recipient of a post-doctoral fellowship awarded by the
   Israel Ministry of Immigrant Absorption, The Center for Absorption in
   Science. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR ABIDIN RR, 1990, J CLIN CHILD PSYCHOL, V19, P298, DOI 10.1207/s15374424jccp1904_1
   Ainsworth M., 1978, PATTERNS ATTACHMENT
   Allhusen V, 2004, DEV PSYCHOPATHOL, V16, P43, DOI 10.1017/S0954579404040404
   ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x
   Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004
   Bakermans-Kranenburg MJ, 2007, J CHILD PSYCHOL PSYC, V48, P1160, DOI 10.1111/j.1469-7610.2007.01801.x
   Bakermans-Kranenburg MJ, 2008, DEV PSYCHOL, V44, P293, DOI 10.1037/0012-1649.44.1.293
   Bakermans-Kranenburg MJ, 2006, DEV PSYCHOBIOL, V48, P406, DOI 10.1002/dev.20152
   BARNARD KE, 1984, INFANT BEHAV DEV, V7, P101, DOI 10.1016/S0163-6383(84)80026-0
   Belsky J, 1997, CHILD DEV, V68, P598, DOI 10.1111/j.1467-8624.1997.tb04221.x
   BELSKY J, 1984, CHILD DEV, V55, P83, DOI 10.2307/1129836
   Belsky J, 2005, ORIGINS SOCIAL MIND, P139
   Belsky J, 2007, CURR DIR PSYCHOL SCI, V16, P300, DOI 10.1111/j.1467-8721.2007.00525.x
   Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376
   Belsky J, 2009, PERSPECT PSYCHOL SCI, V4, P345, DOI 10.1111/j.1745-6924.2009.01136.x
   Boyce WT, 2005, DEV PSYCHOPATHOL, V17, P271, DOI 10.1017/S0954579405050145
   BOYCE WT, 1995, PSYCHOSOM MED, V57, P411, DOI 10.1097/00006842-199509000-00001
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Caspi A, 2002, SCIENCE, V297, P851, DOI 10.1126/science.1072290
   Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925
   Cassidy J., 1999, HDB ATTACHMENT THEOR
   Colin AA, 2010, PEDIATRICS, V126, P115, DOI 10.1542/peds.2009-1381
   Darlow BA, 2009, J PAEDIATR CHILD H, V45, P181, DOI 10.1111/j.1440-1754.2009.01486.x
   DeWolff MS, 1997, CHILD DEV, V68, P571, DOI 10.2307/1132107
   Dollberg S, 2005, ISRAEL MED ASSOC J, V7, P311
   Durston S, 2005, MOL PSYCHIATR, V10, P678, DOI 10.1038/sj.mp.4001649
   Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020
   Ebstein RP, 2006, MOL PSYCHIATR, V11, P427, DOI 10.1038/sj.mp.4001814
   Eisenberg N., 2006, HDB CHILD PSYCHOL, V3, P646, DOI DOI 10.1002/9780470147658.CHPSY0311
   Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P7, DOI 10.1017/S0954579410000611
   Feeley N, 2005, J DEV BEHAV PEDIATR, V26, P24
   Feldman R, 1999, DEV PSYCHOL, V35, P223, DOI 10.1037/0012-1649.35.1.223
   Feldman R, 2004, CHILD DEV, V75, P1774, DOI 10.1111/j.1467-8624.2004.00816.x
   Halpern LF, 2001, J PEDIATR PSYCHOL, V26, P93, DOI 10.1093/jpepsy/26.2.93
   HARRISON MJ, 1990, RES NURS HEALTH, V13, P173, DOI 10.1002/nur.4770130306
   Harrison MJ, 1996, RES NURS HEALTH, V19, P451, DOI 10.1002/(SICI)1098-240X(199612)19:6<451::AID-NUR1>3.3.CO;2-D
   Hughes JR, 2004, CHILD ABUSE NEGLECT, V28, P1081, DOI 10.1016/j.chiabu.2004.02.004
   Kaitz M, 2010, DEV PSYCHOBIOL, V52, P149, DOI 10.1002/dev.20423
   Kluger AN, 2002, MOL PSYCHIATR, V7, P712, DOI 10.1038/sj.mp.4001082
   Knafo A, 2006, TWIN RES HUM GENET, V9, P791, DOI 10.1375/twin.9.6.791
   Knafo A, 2011, DEV PSYCHOPATHOL, V23, P53, DOI 10.1017/S0954579410000647
   Kochanska G, 1997, CHILD DEV, V68, P94, DOI 10.2307/1131928
   KOCHANSKA G, 1993, CHILD DEV, V64, P325, DOI 10.1111/j.1467-8624.1993.tb02913.x
   MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406
   Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475
   Neiderhiser JM, 2004, DEV PSYCHOL, V40, P335, DOI 10.1037/0012-1649.40.3.335
   PLOMIN R, 1977, PSYCHOL BULL, V84, P309, DOI 10.1037/0033-2909.84.2.309
   Robson AL, 1997, J PEDIATR PSYCHOL, V22, P297, DOI 10.1093/jpepsy/22.3.297
   Rutter M., 2006, GENES BEHAV NATURE N
   Sameroff A. J., 1983, HDB CHILD PSYCHOL, V1, P237
   Singer LT, 1999, JAMA-J AM MED ASSOC, V281, P799, DOI 10.1001/jama.281.9.799
   Singer LT, 2007, J PEDIATR-US, V151, P463, DOI 10.1016/j.jpeds.2007.04.012
   Taylor SE, 2006, BIOL PSYCHIAT, V60, P671, DOI 10.1016/j.biopsych.2006.04.019
   van Ijzendoorn MH, 2008, GENES BRAIN BEHAV, V7, P403, DOI 10.1111/j.1601-183X.2007.00362.x
   Van Ijzendoorn MH, 2006, ATTACH HUM DEV, V8, P291, DOI 10.1080/14616730601048159
   van Ijzendoorn MH, 2010, BIOL PSYCHIAT, V68, P405, DOI 10.1016/j.biopsych.2010.05.008
   VOLLING BL, 1992, CHILD DEV, V63, P1209, DOI 10.2307/1131528
   WASHINGTON J, 1986, J AM ACAD CHILD PSY, V25, P493, DOI 10.1016/S0002-7138(10)60008-8
   Wijnroks L, 1999, INF MENTAL HLTH J, V20, P393, DOI 10.1002/(SICI)1097-0355(199924)20:4<393::AID-IMHJ3>3.0.CO;2-I
   Zuckerman M, 1999, VULNERABILITY PSYCHO
NR 60
TC 15
Z9 15
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 16
PY 2011
VL 6
IS 5
AR e19765
DI 10.1371/journal.pone.0019765
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 764TP
UT WOS:000290656300024
PM 21603618
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU D'Amato, FR
   Zanettini, C
   Lampis, V
   Coccurello, R
   Pascucci, T
   Ventura, R
   Puglisi-Allegra, S
   Spatola, CAM
   Pesenti-Gritti, P
   Oddi, D
   Moles, A
   Battaglia, M
AF D'Amato, Francesca R.
   Zanettini, Claudio
   Lampis, Valentina
   Coccurello, Roberto
   Pascucci, Tiziana
   Ventura, Rossella
   Puglisi-Allegra, Stefano
   Spatola, Chiara A. M.
   Pesenti-Gritti, Paola
   Oddi, Diego
   Moles, Anna
   Battaglia, Marco
TI Unstable Maternal Environment, Separation Anxiety, and Heightened CO2
   Sensitivity Induced by Gene-by-Environment Interplay
SO PLOS ONE
LA English
DT Article
ID CHILDHOOD PARENTAL LOSS; PANIC DISORDER; CARBON-DIOXIDE; VENTILATORY
   RESPONSE; INBRED STRAINS; MOUSE MODELS; AWAKE RAT; BEHAVIOR; MICE; TWIN
AB Background: In man, many different events implying childhood separation from caregivers/unstable parental environment are associated with heightened risk for panic disorder in adulthood. Twin data show that the occurrence of such events in childhood contributes to explaining the covariation between separation anxiety disorder, panic, and the related psychobiological trait of CO2 hypersensitivity. We hypothesized that early interference with infant-mother interaction could moderate the interspecific trait of response to CO2 through genetic control of sensitivity to the environment.
   Methodology: Having spent the first 24 hours after birth with their biological mother, outbred NMRI mice were cross-fostered to adoptive mothers for the following 4 post-natal days. They were successively compared to normally-reared individuals for: number of ultrasonic vocalizations during isolation, respiratory physiology responses to normal air (20%O-2), CO2-enriched air (6% CO2), hypoxic air (10%O-2), and avoidance of CO2-enriched environments.
   Results: Cross-fostered pups showed significantly more ultrasonic vocalizations, more pronounced hyperventilatory responses (larger tidal volume and minute volume increments) to CO2-enriched air and heightened aversion towards CO2-enriched environments, than normally-reared individuals. Enhanced tidal volume increment response to 6% CO2 was present at 16-20, and 75-90 postnatal days, implying the trait's stability. Quantitative genetic analyses of unrelated individuals, sibs and half-sibs, showed that the genetic variance for tidal volume increment during 6% CO2 breathing was significantly higher (Bartlett chi = 8.3, p = 0.004) among the cross-fostered than the normally-reared individuals, yielding heritability of 0.37 and 0.21 respectively. These results support a stress-diathesis model whereby the genetic influences underlying the response to 6% CO2 increase their contribution in the presence of an environmental adversity. Maternal grooming/licking behaviour, and corticosterone basal levels were similar among cross-fostered and normally-reared individuals.
   Conclusions: A mechanism of gene-by-environment interplay connects this form of early perturbation of infant-mother interaction, heightened CO2 sensitivity and anxiety. Some non-inferential physiological measurements can enhance animal models of human neurodevelopmental anxiety disorders.
C1 [Lampis, Valentina; Spatola, Chiara A. M.; Pesenti-Gritti, Paola; Battaglia, Marco] Univ Vita Salute San Raffaele, Acad Ctr Study Behav Plast, Milan, Italy.
   [Pascucci, Tiziana; Ventura, Rossella; Puglisi-Allegra, Stefano] Santa Lucia Fdn, European Ctr Brain Res CERC, Rome, Italy.
   [Pascucci, Tiziana; Puglisi-Allegra, Stefano] Univ Roma La Sapienza, Dept Psychol, Rome, Italy.
   [Ventura, Rossella] Univ Aquila, Dept Biomed Sci & Technol, I-67100 Laquila, Italy.
   [Moles, Anna] Genomnia, Lainate, Italy.
   [Battaglia, Marco] Ist Sci San Raffaele, Dept Clin Neurosci, Milan, Italy.
   [D'Amato, Francesca R.; Zanettini, Claudio; Coccurello, Roberto; Oddi, Diego; Moles, Anna] CNR, Cell Biol & Neurobiol Inst, Rome, Italy.
RP D'Amato, FR (reprint author), CNR, Cell Biol & Neurobiol Inst, Rome, Italy.
EM marco.battaglia@unisr.it
RI Coccurello, Roberto/F-8460-2015
OI Pascucci, Tiziana/0000-0003-1520-7373; Spatola,
   Chiara/0000-0003-4807-9566; COCCURELLO, ROBERTO/0000-0001-7059-7015;
   Moles, Anna/0000-0002-5805-5763; D'Amato, Francesca/0000-0002-4577-4574
FU Italian Ministry of University; Fondazione Telethon
FX Supported in part by grants from the Italian Ministry of University and
   Research PRIN 2008 grant (MB and FRD), from The Region Lombardy Grant
   Funding for Scientific and Technological Partnerships grant SAL-25/16848
   (MB), and by an award granted by the Anna Villa & Felice Rusconi
   Foundation (MB). FRD, AM, CZ, RC and DO were supported by funds from
   Regione Lazio for "Sviluppo della Ricerca sul Cervello"; FRD and AM were
   also partially supported by Telethon, Italy (Grant no. GGP05220). VL,
   CAMS, and PP-G are in the San Raffaele University PhD Program in
   Developmental Psychopathology, supported in part by the CARIPLO
   Foundation "Human Talents" Grant for Academic Centres of Excellence in
   Post-Graduate Teaching (Dr. Battaglia, recipient). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR American Psychiatric Association, 1994, DIAGN STAT MAN MENT
   ANDERSON DJ, 1984, AM J PSYCHIAT, V141, P572
   Barbazanges A, 1996, J NEUROSCI, V16, P7783
   Bartolomucci A, 2004, GENES BRAIN BEHAV, V3, P115, DOI 10.1111/j.1601-183X.2003.00059.x
   BATTAGLIA M, 1995, AM J PSYCHIAT, V152, P1362
   Battaglia M, 2005, NEUROSCI BIOBEHAV R, V29, P169, DOI 10.1016/j.neubiorev.2004.06.013
   Battaglia M, 2008, AM J MED GENET B, V147B, P586, DOI 10.1002/ajmg.b.30647
   Battaglia M, 2007, J PSYCHIATR RES, V41, P906, DOI 10.1016/j.jpsychires.2006.12.002
   Battaglia M, 2009, ARCH GEN PSYCHIAT, V66, P64, DOI 10.1001/archgenpsychiatry.2008.513
   Bavis RW, 2008, J APPL PHYSIOL, V104, P1220, DOI 10.1152/japplphysiol.01086.2007
   Brandes Mina, 2006, Curr Psychiatry Rep, V8, P263, DOI 10.1007/s11920-006-0061-8
   Brannan S, 2001, P NATL ACAD SCI USA, V98, P2029, DOI 10.1073/pnas.98.4.2029
   Cabib S, 2000, SCIENCE, V289, P463, DOI 10.1126/science.289.5478.463
   Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925
   Cayirlioglu P, 2008, SCIENCE, V319, P1256, DOI 10.1126/science.1149483
   Colasanti A, 2008, NEUROPSYCHOPHARMACOL, V33, P3103, DOI 10.1038/npp.2008.31
   Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825
   Falconer D. S., 1996, INTRO QUANTITATIVE G
   Forman EM, 2003, J CLIN CHILD ADOLESC, V32, P94, DOI 10.1207/15374420360533095
   Fyer AJ, 1999, AM J MED GENET, V88, P173, DOI 10.1002/(SICI)1096-8628(19990416)88:2<173::AID-AJMG15>3.3.CO;2-R
   Gaultier C, 2008, J APPL PHYSIOL, V104, P1522, DOI 10.1152/japplphysiol.01266.2007
   Genest SE, 2004, J PHYSIOL-LONDON, V554, P543, DOI 10.1113/jphysiol.2003.052894
   Genest SE, 2007, J APPL PHYSIOL, V102, P1416, DOI 10.1152/japplphysiol.00454.2006
   Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636
   Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186
   GRIEZ E, 2007, PLOS ONE, V10, pE987
   Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105
   Han F, 2000, RESP PHYSIOL, V121, P247, DOI 10.1016/S0034-5687(00)00132-8
   Jacob RG, 1996, AM J PSYCHIAT, V153, P503
   Kas MJH, 2007, MOL PSYCHIATR, V12, P324, DOI 10.1038/sj.mp.4001979
   KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P109
   KLEIN DF, 1993, ARCH GEN PSYCHIAT, V50, P306
   Klein RG, 1995, CLIN NEUROPHARMACOL, V18, pS7
   MACLEAN PD, 1985, ARCH GEN PSYCHIAT, V42, P405
   Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008
   Mather K, 1982, BIOMETRICAL GENETICS
   MILLHORN DE, 1986, J APPL PHYSIOL, V61, P1249
   Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943
   Ogliari A, 2010, PSYCHOTHER PSYCHOSOM, V79, P48, DOI 10.1159/000259417
   Pine DS, 2000, ARCH GEN PSYCHIAT, V57, P960, DOI 10.1001/archpsyc.57.10.960
   Preter M, 2008, PROG NEURO-PSYCHOPH, V32, P603, DOI 10.1016/j.pnpbp.2007.07.029
   Purcell S, 2002, TWIN RES, V5, P554, DOI 10.1375/136905202762342035
   Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944
   Ricceri L, 2007, BEHAV BRAIN RES, V176, P40, DOI 10.1016/j.bbr.2006.08.024
   Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x
   Shoji H, 2006, PHYSIOL BEHAV, V89, P320, DOI 10.1016/j.physbeh.2006.06.012
   Shoji H, 2009, DEV PSYCHOBIOL, V51, P345, DOI 10.1002/dev.20375
   Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754
   Smoller JW, 1998, AM J PSYCHIAT, V155, P1152, DOI 10.1176/ajp.155.9.1152
   Spatola CAM, 2011, AM J MED GENET B, V156B, P79, DOI 10.1002/ajmg.b.31144
   Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980
   TANKERSLEY CG, 1994, AM J PHYSIOL-REG I, V267, pR1371
   Terleph TA, 2006, AM J PSYCHIAT, V163, P738, DOI 10.1176/appi.ajp.163.4.738
   Upton KJ, 2010, DEV PSYCHOBIOL, V52, P453, DOI 10.1002/dev.20448
   van Duinen MA, 2007, INT J NEUROPSYCHOPH, V10, P797
   Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322
   Warn PA, 2003, LAB ANIM-UK, V37, P126, DOI 10.1258/00236770360563769
   WESTBERG P, 1991, BIOL PSYCHIAT, V30, P247, DOI 10.1016/0006-3223(91)90109-Y
   Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029
NR 59
TC 48
Z9 48
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 8
PY 2011
VL 6
IS 4
AR e18637
DI 10.1371/journal.pone.0018637
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 747AP
UT WOS:000289292800033
PM 21494633
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Scharf, SH
   Liebl, C
   Binder, EB
   Schmidt, MV
   Muller, MB
AF Scharf, Sebastian H.
   Liebl, Claudia
   Binder, Elisabeth B.
   Schmidt, Mathias V.
   Mueller, Marianne B.
TI Expression and Regulation of the Fkbp5 Gene in the Adult Mouse Brain
SO PLOS ONE
LA English
DT Article
ID POSTTRAUMATIC-STRESS-DISORDER; MESSENGER-RIBONUCLEIC-ACID;
   GLUCOCORTICOID-RECEPTOR; TREATMENT RESPONSE; POSTNATAL ONTOGENY;
   CHILDHOOD TRAUMA; DEPRESSION; POLYMORPHISMS; RISK; ASSOCIATION
AB Background: Chronic stress has been found to be a major risk factor for various human pathologies. Stress activates the hypothalamic-pituitary-adrenal (HPA) axis, which is tightly regulated via, among others, the glucocorticoid receptor (GR). The activity of the GR is modulated by a variety of proteins, including the co-chaperone FK506 binding protein 51 (FKBP5). Although FKBP5 has been associated with risk for affective disorders and has been implicated in GR sensitivity, previous studies focused mainly on peripheral blood, while information about basal distribution and induction in the central nervous system are sparse.
   Methodology/Principal Findings: In the present study, we describe the basal expression pattern of Fkbp5 mRNA in the brain of adult male mice and show the induction of Fkbp5 mRNA via dexamethasone treatment or different stress paradigms. We could show that Fkbp5 is often, but not exclusively, expressed in regions also known for GR expression, for example the hippocampus. Furthermore, we were able to induce Fkbp5 expression via dexamethasone in the CA1 and DG subregions of the hippocampus, the paraventricular nucleus (PVN) and the central amygdala (CeA). Increase of Fkbp5 mRNA was also found after restrained stress and 24 hours of food deprivation in the PVN and the CeA, while in the hippocampus only food deprivation caused an increase in Fkbp5 mRNA.
   Conclusions/Significance: Interestingly, regions with a low basal expression showed higher increase in Fkbp5 mRNA following induction than regions with high basal expression, supporting the hypothesis that GR sensitivity is, at least partly, mediated via Fkbp5. In addition, this also supports the use of Fkbp5 gene expression as a marker for GR sensitivity. In summary, we were able to give an overview of the basal expression of fkbp5 mRNA as well as to extend the findings of induction of Fkbp5 and its regulatory influence on GR sensitivity from peripheral blood to the brain.
C1 [Scharf, Sebastian H.; Liebl, Claudia; Mueller, Marianne B.] Max Planck Inst Psychiat, Res Grp Mol Stress Physiol, Munich, Germany.
   [Binder, Elisabeth B.] Max Planck Inst Psychiat, Res Grp Mol Genet Affect Disorders, Munich, Germany.
   [Schmidt, Mathias V.] Max Planck Inst Psychiat, Res Grp Neurobiol Stress, D-80804 Munich, Germany.
RP Scharf, SH (reprint author), Max Planck Inst Psychiat, Res Grp Mol Stress Physiol, Munich, Germany.
EM sscharf@mpipsykl.mpg.de
RI Binder, Elisabeth/K-8905-2014
OI Schmidt, Mathias/0000-0002-3788-2268; Scharf,
   Sebastian/0000-0002-9129-4723
FU Max Planck Society
FX The present study was funded by the Max Planck Society. The funding
   source had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479
   Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291
   Brent D, 2010, AM J PSYCHIAT, V167, P190, DOI 10.1176/appi.ajp.2009.09040576
   Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925
   Chandola T, 2006, BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80
   Checkley S, 1996, BRIT MED BULL, V52, P597
   de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683
   Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107
   Elenkov IJ, 2000, ANN NY ACAD SCI, V917, P94
   GRAD I, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI DOI 10.1016/J.MCE.2007.05.018)
   Heim C, 2004, NEUROPSYCHOPHARMACOL, V29, P641, DOI 10.1038/sj.npp.1300397
   Heim C, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.041.2009
   Hubler TR, 2004, CELL STRESS CHAPERON, V9, P243, DOI 10.1379/CSC-32R.1
   Ising M, 2008, EUR J NEUROSCI, V28, P389, DOI 10.1111/j.1460-9568.2008.06332.x
   Ising M, 2007, BIOL PSYCHIAT, V62, P47, DOI 10.1016/j.biopsych.2006.07.039
   JUSTER RP, 2009, NEUROSCIENC IN PRESS
   Koenen KC, 2005, MOL PSYCHIATR, V10, P1058, DOI 10.1038/sj.mp.4001727
   LAVEBRATT C, 2010, J AFFECTIVE IN PRESS
   Lee RS, 2010, ENDOCRINOLOGY, V151, P4332, DOI 10.1210/en.2010-0225
   Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453
   Lekman M, 2008, BIOL PSYCHIAT, V63, P1103, DOI 10.1016/j.biopsych.2007.10.026
   Lightman SL, 2008, J NEUROENDOCRINOL, V20, P880, DOI 10.1111/j.1365-2826.2008.01711.x
   Navailles S, 2010, DEV NEUROSCI-BASEL, V32, P139, DOI 10.1159/000293989
   Paakinaho V, 2010, MOL ENDOCRINOL, V24, P511, DOI 10.1210/me.2009-0443
   Pahwa P, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-84
   Paxinos G, 2001, MOUSE BRAIN STEREOTA
   PRATT WB, 1993, J BIOL CHEM, V268, P21455
   Pryce CR, 2008, BRAIN RES REV, V57, P596, DOI 10.1016/j.brainresrev.2007.08.005
   Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0
   Roy A, 2010, NEUROPSYCHOPHARMACOL, V35, P1674, DOI 10.1038/npp.2009.236
   Schmidt MV, 2007, PSYCHONEUROENDOCRINO, V32, P417, DOI 10.1016/j.psyneuen.2007.02.011
   SOUSA RJ, 1989, MOL ENDOCRINOL, V3, P481, DOI 10.1210/mend-3-3-481
   Szymanska M, 2009, PSYCHONEUROENDOCRINO, V34, P822, DOI 10.1016/j.psyneuen.2008.12.012
   Tatro ET, 2009, J NEUROIMMUNE PHARM, V4, P218, DOI 10.1007/s11481-009-9146-6
   Tyrka AR, 2009, BIOL PSYCHIAT, V66, P681, DOI 10.1016/j.biopsych.2009.05.012
   VANEEKELEN JAM, 1991, DEV BRAIN RES, V61, P33, DOI 10.1016/0165-3806(91)90111-U
   Vermeer H, 2004, EUR J ENDOCRINOL, V150, P41, DOI 10.1530/eje.0.1500041
   Vermeer H, 2003, J CLIN ENDOCR METAB, V88, P277, DOI 10.1210/jc.2002-020354
   Wang JL, 2005, PSYCHOL MED, V35, P865, DOI 10.1017/S0033291704003241
   Willour VL, 2008, MOL PSYCHIATR, V14, P261
   Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200
   Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104
   Xie P, 2010, NEUROPSYCHOPHARMACOL, V35, P1684, DOI 10.1038/npp.2010.37
   Yao M, 2008, J COMP NEUROL, V508, P967, DOI 10.1002/cne.21716
   Zobel A, 2010, INT J NEUROPSYCHOPH, V13, P649, DOI 10.1017/S1461145709991155
   Zobel AW, 1999, AM J PSYCHIAT, V156, P949, DOI 10.1176/ajp.156.6.949
NR 46
TC 87
Z9 88
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 9
PY 2011
VL 6
IS 2
AR e16883
DI 10.1371/journal.pone.0016883
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 721NN
UT WOS:000287361700050
PM 21347384
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU Rivero, O
   Reif, A
   Sanjuan, J
   Molto, MD
   Kittel-Schneider, S
   Najera, C
   Topner, T
   Lesch, KP
AF Rivero, Olga
   Reif, Andreas
   Sanjuan, Julio
   Molto, Maria D.
   Kittel-Schneider, Sarah
   Najera, Carmen
   Toepner, Theresia
   Lesch, Klaus-Peter
TI Impact of the AHI1 Gene on the Vulnerability to Schizophrenia: A
   Case-Control Association Study
SO PLOS ONE
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; JOUBERT-SYNDROME; CEREBELLAR DEVELOPMENT;
   BIPOLAR-DISORDER; CHROMOSOME 6Q23; SUSCEPTIBILITY; LOCUS; METAANALYSIS;
   EXPRESSION; MUTATIONS
AB Background: The Abelson helper integration-1 (AHI1) gene is required for both cerebellar and cortical development in humans. While the accelerated evolution of AHI1 in the human lineage indicates a role in cognitive (dys) function, a linkage scan in large pedigrees identified AHI1 as a positional candidate for schizophrenia. To further investigate the contribution of AHI1 to the susceptibility of schizophrenia, we evaluated the effect of AHI1 variation on the vulnerability to psychosis in two samples from Spain and Germany.
   Methodology/Principal Findings: 29 single-nucleotide polymorphisms (SNPs) located in a genomic region including the AHI1 gene were genotyped in two samples from Spain (280 patients with psychotic disorders; 348 controls) and Germany (247 patients with schizophrenic disorders; 360 controls). Allelic, genotypic and haplotype frequencies were compared between cases and controls in both samples separately, as well as in the combined sample. The effect of genotype on several psychopathological measures (BPRS, KGV, PANSS) assessed in a Spanish subsample was also evaluated. We found several significant associations in the Spanish sample. Particularly, rs7750586 and rs911507, both located upstream of the AHI1 coding region, were found to be associated with schizophrenia in the analysis of genotypic (p = 0.0033, and 0.031, respectively) and allelic frequencies (p = 0.001 in both cases). Moreover, several other risk and protective haplotypes were detected (0.006<p<0.036). Joint analysis also supported the association of rs7750586 and rs911507 with the risk for schizophrenia. The analysis of clinical measures also revealed an effect on symptom severity (minimum P value = 0.0037).
   Conclusions/Significance: Our data support, in agreement with previous reports, an effect of AHI1 variation on the susceptibility to schizophrenia in central and southern European populations.
C1 [Rivero, Olga; Reif, Andreas; Kittel-Schneider, Sarah; Toepner, Theresia; Lesch, Klaus-Peter] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Unit Mol Psychiat, Wurzburg, Germany.
   [Rivero, Olga; Molto, Maria D.; Najera, Carmen] Univ Valencia, Dept Genet, Valencia, Spain.
   [Rivero, Olga; Sanjuan, Julio; Molto, Maria D.; Najera, Carmen] Ctr Biomed Res Network Mental Hlth CIBERSAM, Valencia, Spain.
   [Sanjuan, Julio] Univ Valencia, Dept Med, Teaching Unit Psychiat, Valencia, Spain.
RP Rivero, O (reprint author), Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Unit Mol Psychiat, Wurzburg, Germany.
EM RiveroMar_O@klinik.uni-wuerzburg.de
RI Lesch, Klaus-Peter/J-4906-2013
OI Lesch, Klaus-Peter/0000-0001-8348-153X; Rivero,
   Olga/0000-0002-2664-4053; Kittel-Schneider, Sarah/0000-0003-3057-6150;
   Molto, Maria Dolores/0000-0001-5219-2022
FU Spanish Ministry of Health: Instituto de Salud Carlos III [FIS02/0018];
   Red de Genotipacion y Psiquiatria Genetica-ISCIII [G03/184]; Red de
   Enfermedades Mentales (REM-TAP Network); CIBER de Salud Mental
   (CIBERSAM); Deutsche Forschungsgemeinschaft [RE1632/1-5];
   Bundesministerium fur Bildung und Forschung (IZKF Wurzburg) [01KS9603];
   European Comission [LSHM-CT-2003-503474]
FX This study was supported by the Spanish Ministry of Health: Instituto de
   Salud Carlos III, FIS02/0018 (to OR, JS, and CN), Red de Genotipacion y
   Psiquiatria Genetica-ISCIII G03/184 (to OR, JS, MDM and CN), Red de
   Enfermedades Mentales (REM-TAP Network) and CIBER de Salud Mental
   (CIBERSAM) (to OR, JS, MDM and CN). Furthermore, this work was supported
   by the Deutsche Forschungsgemeinschaft (Grant RE1632/1-5 to AR, Clinical
   Research Unit - KFO 125 to AR and KPL; SFB 581 to KPL, SFB TRR 58 to AR
   and KPL), Bundesministerium fur Bildung und Forschung (IZKF Wurzburg,
   01KS9603, to KPL; IZKF N-27-N, to AR) and the European Comission
   (NEWMOOD LSHM-CT-2003-503474, to KPL). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alvarez Retuerto AI, 2008, HUM MOL GENET, V17, P3887, DOI 10.1093/hmg/ddn291
   Amann-Zalcenstein D, 2006, EUR J HUM GENET, V14, P1111, DOI 10.1038/sj.ejhg.5201675
   Andreasen NC, 1998, SCHIZOPHRENIA BULL, V24, P203, DOI 10.1093/oxfordjournals.schbul.a033321
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012
   Burmeister M, 2008, NAT REV GENET, V9, P527, DOI 10.1038/nrg2381
   Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925
   Crow TJ, 1997, SCHIZOPHR RES, V28, P127, DOI 10.1016/S0920-9964(97)00110-2
   Dean B, 2009, AUST NZ J PSYCHIAT, V43, P13, DOI 10.1080/00048670802534416
   Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985
   Doering JE, 2008, J COMP NEUROL, V511, P238, DOI 10.1002/cne.21824
   Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252
   Dudbridge F, 2006, 20065 MRC BIOST UN
   Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419
   Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209
   Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424
   Glahn DC, 2005, HUM BRAIN MAPP, V25, P60, DOI 10.1002/hbm.20138
   Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558
   Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210
   Hirayasu Y, 2007, NEUROPATHOLOGY, V27, P601, DOI 10.1111/j.1440-1789.2007.00827.x
   Horrobin DF, 1998, MED HYPOTHESES, V50, P269, DOI 10.1016/S0306-9877(98)90000-7
   Ingason A, 2007, EUR J HUM GENET, V15, P988, DOI 10.1038/sj.ejhg.5201848
   Ingason A, 2010, HUM MOL GENET, V19, P1379, DOI 10.1093/hmg/ddq009
   Jablensky A, 1992, Psychol Med Monogr Suppl, V20, P1
   JABLENSKY A, 2003, SCHIZOPHRENIA
   Kirov G, 2009, MOL PSYCHIATR, V14, P796, DOI 10.1038/mp.2008.33
   Kohn Y, 2005, MOL PSYCHIATR, V10, P1062, DOI 10.1038/sj.mp.4001738
   Lang UE, 2007, CELL PHYSIOL BIOCHEM, V20, P687, DOI 10.1159/000110430
   Langefeld Carl D., 2007, V404, P431, DOI 10.1007/978-1-59745-530-5_21
   Lerer B, 2003, MOL PSYCHIATR, V8, P488, DOI 10.1038/sj.mp.4001322
   Levi A, 2005, EUR J HUM GENET, V13, P763, DOI 10.1038/sj.ejhg.5201406
   Louie CM, 2005, HUM MOL GENET, V14, pR235, DOI 10.1093/hmg/ddi264
   Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337
   Mutsuddi M, 2006, AM J HUM GENET, V79, P903, DOI 10.1086/508942
   Peltonen L, 2006, HUM MOL GENET, V15, pR67, DOI 10.1093/hmg/ddl060
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Reif A, 2006, MOL PSYCHIATR, V11, P286, DOI 10.1038/sj.mp.4001779
   RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x
   Selch S, 2007, BIOL PSYCHIAT, V61, P1211, DOI 10.1016/j.biopsych.2006.08.030
   Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143
   Sheng G, 2008, J CLIN INVEST, V118, P2785, DOI 10.1172/JCI35339
   Shergill SS, 2000, ARCH GEN PSYCHIAT, V57, P1033, DOI 10.1001/archpsyc.57.11.1033
   Shih RA, 2004, INT REV PSYCHIATR, V16, P260, DOI 10.1080/09540260400014401
   Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268
   Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25
   Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268
   TORRI F, 2010, FASEB J IN PRESS
   White T, 2008, SCHIZOPHRENIA BULL, V34, P18, DOI 10.1093/schbul/sbm110
   Yu FL, 2009, HUM MOL GENET, V18, P4853, DOI 10.1093/hmg/ddp457
NR 49
TC 13
Z9 13
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 18
PY 2010
VL 5
IS 8
AR e12254
DI 10.1371/journal.pone.0012254
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 639XY
UT WOS:000281011600023
PM 20805890
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

PT J
AU van der Veen, R
   Koehl, M
   Abrous, DN
   de Kloet, ER
   Piazza, PV
   Deroche-Gamonet, V
AF van der Veen, Rixt
   Koehl, Muriel
   Abrous, D. Nora
   de Kloet, E. Ronald
   Piazza, Pier-Vincenzo
   Deroche-Gamonet, Veronique
TI Maternal Environment Influences Cocaine Intake in Adulthood in a
   Genotype-Dependent Manner
SO PLOS ONE
LA English
DT Article
ID SELF-MEDICATION HYPOTHESIS; SUBSTANCE USE DISORDERS; ANXIETY-LIKE
   BEHAVIOR; OLFACTORY BULBECTOMY; ANIMAL-MODELS; MOUSE STRAINS; C57BL/6
   MICE; LIFE STRESS; DRUG-ABUSE; RAT MODEL
AB Background: Accumulating epidemiological evidence points to the role of genetic background as a modulator of the capacity of adverse early experiences to give rise to mental illness. However, direct evidence of such gene-environment interaction in the context of substance abuse is scarce. In the present study we investigated whether the impact of early life experiences on cocaine intake in adulthood depends on genetic background. In addition, we studied other behavioral dimensions associated with drug abuse, i.e. anxiety- and depression-related behaviors.
   Methodology/Principal Findings: For this purpose, we manipulated the maternal environment of two inbred mouse strains, the C57BL/6J and DBA/2J by fostering them with non-related mothers, i.e. the C3H/HeN and AKR strains. These mother strains show respectively high and low pup-oriented behavior. As adults, C57BL/6J and DBA/2J were tested either for cocaine intravenous self-administration or in the elevated plus-maze and forced swim test (FST). We found that the impact of maternal environment on cocaine use and a depression-related behavior depends upon genotype, as cocaine self-administration and behavior in the FST were influenced by maternal environment in DBA/2J, but not in C57BL/6J mice. Anxiety was not influenced by maternal environment in either strain.
   Conclusions/Significance: Our experimental approach could contribute to the identification of the psychobiological factors determining the susceptibility or the resilience of certain individuals to develop psychopathologies.
C1 [van der Veen, Rixt; Koehl, Muriel; Abrous, D. Nora; Piazza, Pier-Vincenzo; Deroche-Gamonet, Veronique] INSERM, U862, Bordeaux, France.
   [van der Veen, Rixt; de Kloet, E. Ronald] Leiden Univ, Med Ctr, Amsterdam Ctr Drug Res, Div Med Pharmacol, Leiden, Netherlands.
RP van der Veen, R (reprint author), INSERM, U862, Bordeaux, France.
EM deroche@bordeaux.inserm.fr
RI van der Veen, Rixt/F-1673-2018; Abrous, Nora-Djoher/N-6977-2017;
   Deroche-Gamonet, Veronique/E-5728-2010; Koehl, Muriel/C-3698-2011
OI Koehl, Muriel/0000-0002-7601-1422; de Kloet, Ron/0000-0001-9176-1830;
   abrous, nora/0000-0002-8589-305X; Deroche-Gamonet,
   Veronique/0000-0002-9704-6624
FU NWO/INSERM/ZON [AH002G, 985-10-014]; University of Bordeaux 2
FX This research was supported by the NWO/INSERM/ZON grants AH002G and
   985-10-014 and the university of Bordeaux 2. Funders had no role in
   design and conduct of the study, they had no role in collection,
   analysis and interpretation of the data, in the preparation, review or
   approval of the manuscript.
CR Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2
   Ator NA, 2003, DRUG ALCOHOL DEPEN, V70, pS55, DOI 10.1016/S0376-8716(03)00099-1
   Brady Kathleen T, 2007, Curr Psychiatry Rep, V9, P374, DOI 10.1007/s11920-007-0048-0
   CADORET RJ, 1995, ARCH GEN PSYCHIAT, V52, P916
   Calcagnetti DJ, 1996, PHYSIOL BEHAV, V59, P597, DOI 10.1016/0031-9384(95)02119-1
   CALDJI C, 2004, MAT BEHAV REGULATES
   Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Caspi A, 2002, SCIENCE, V297, P851, DOI 10.1126/science.1072290
   Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925
   CUTRONA CE, 1994, COMPR PSYCHIAT, V35, P171, DOI 10.1016/0010-440X(94)90188-0
   De Bellis MD, 2002, PSYCHONEUROENDOCRINO, V27, P155, DOI 10.1016/S0306-4530(01)00042-7
   Deroche-Gamonet V, 2003, J NEUROSCI, V23, P4785
   File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3
   Foley DL, 2004, ARCH GEN PSYCHIAT, V61, P738, DOI 10.1001/archpsyc.61.7.738
   Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038
   Friedman E, 2006, DEV PSYCHOBIOL, V48, P169, DOI 10.1002/dev.20119
   GAWIN FH, 1991, SCIENCE, V251, P1580, DOI 10.1126/science.2011738
   Gordon HW, 2002, PSYCHONEUROENDOCRINO, V27, P115, DOI 10.1016/S0306-4530(01)00039-7
   Heim C, 2004, NEUROPSYCHOPHARMACOL, V29, P641, DOI 10.1038/sj.npp.1300397
   Jaffee SR, 2005, DEV PSYCHOPATHOL, V17, P67, DOI 10.1017/S0954579405050042
   Kendler KS, 2005, AM J PSYCHIAT, V162, P1243, DOI 10.1176/appi.ajp.162.7.1243
   Khantzian EJ, 1997, HARVARD REV PSYCHIAT, V4, P231, DOI 10.3109/10673229709030550
   KHANTZIAN EJ, 1985, AM J PSYCHIAT, V142, P1259
   LUMIA AR, 1992, BRAIN RES, V587, P181, DOI 10.1016/0006-8993(92)90995-L
   MARKOU A, 1992, NEUROPSYCHOPHARMACOL, V7, P213
   Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161
   Millstein RA, 2006, GENES BRAIN BEHAV, V5, P346, DOI 10.1111/j.1601-183X.2005.00172.x
   Millstein RA, 2007, NEUROSCI BIOBEHAV R, V31, P3, DOI 10.1016/j.neubiorev.2006.05.003
   Moffitt TE, 2006, PERSPECT PSYCHOL SCI, V1, P5, DOI 10.1111/j.1745-6916.2006.00002.x
   Newport DJ, 2002, AM J PSYCHIAT, V159, P1265, DOI 10.1176/appi.ajp.159.8.1265
   OAKLEYBROWNE MA, 1995, J AFFECT DISORDERS, V34, P13, DOI 10.1016/0165-0327(94)00099-U
   Parfitt DB, 2007, HORM BEHAV, V52, P417, DOI 10.1016/j.yhbeh.2007.06.002
   PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7
   PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327
   Priebe K, 2005, DEV PSYCHOBIOL, V47, P398, DOI 10.1002/dev.20098
   RANDALL CL, 1975, J STUD ALCOHOL, V36, P973, DOI 10.15288/jsa.1975.36.973
   Roman E, 2005, ALCOHOL CLIN EXP RES, V29, P591, DOI 10.1097/01.ALC.0000158933.70242.FC
   Romeo RD, 2003, HORM BEHAV, V43, P561, DOI 10.1016/S0018-506X(03)00063-1
   Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x
   Sameroff AJ, 2000, DEV PSYCHOPATHOL, V12, P297, DOI 10.1017/S0954579400003035
   Sigvardsson S, 1996, ARCH GEN PSYCHIAT, V53, P681
   Silberg J, 2001, BRIT J PSYCHIAT, V179, P116, DOI 10.1192/bjp.179.2.116
   Slattery DA, 2007, PSYCHOPHARMACOLOGY, V190, P555, DOI 10.1007/s00213-006-0630-x
   Tienari P, 2004, BRIT J PSYCHIAT, V184, P216, DOI 10.1192/bjp.184.3.216
   van der Kam EL, 2005, NEUROPHARMACOLOGY, V48, P685, DOI 10.1016/j.neuropharm.2004.12.014
   van der Veen R, 2008, GENES BRAIN BEHAV, V7, P184, DOI 10.1111/j.1601-183X.2007.00337.x
   van der Veen R, 2007, PSYCHOPHARMACOLOGY, V193, P179, DOI 10.1007/s00213-007-0777-0
   Veenema AH, 2007, PSYCHONEUROENDOCRINO, V32, P437, DOI 10.1016/j.psyneuen.2007.02.008
   Weiss RD, 2004, J SUBST ABUSE TREAT, V27, P307, DOI 10.1016/j.jsat.2004.10.001
   Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097
   Willner P, 2002, BEHAV PHARMACOL, V13, P169, DOI 10.1097/00008877-200205000-00001
NR 52
TC 29
Z9 29
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 21
PY 2008
VL 3
IS 5
AR e2245
DI 10.1371/journal.pone.0002245
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 391UK
UT WOS:000262258700053
PM 18493309
OA DOAJ Gold, Green Published
DA 2019-06-25
ER

EF